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Abstract 
Systems Biology aims to integrate experimental and computational approaches with the 
purpose of explaining and predicting the organisms' behavior. The development of 
mathematical models in silico gives us a better in-depth knowledge of their biological 
mechanism. Bioinformatics tools enabled the integration of a large amount of complex 
biological data into computer models, but also capable to  perform computational 
simulations with these models, that can predict the organisms' phenotypic behavior in 
different conditions. 
Up to date, genome-scale metabolic models (GSMMs) include several metabolic 
components of an organism. These are related to the metabolic capabilities encoded in 
the genome. In recent years, multiple GSMMs have been built by several research 
groups. With the increase in number, of these models, important issues regarding the 
standardization have arisen, a common problem is the different nomenclatures used by 
each of the research groups. 
In this work, the major focus is to address these problems, specifically for the human 
GSSMs. Therefore, the two most recent human GSMMs were selected to go through a 
data integration process. 
Integration strategies of these models most important entities (metabolites and 
reactions), were defined based on an exhaustive analysis of the models. The broad 
knowledge of their attributes enabled the creation of effective and efficient integration 
methods, supported by a core database developed in the local research group. 
The final result of this work, is a unified repository of the human metabolism. It contains 
all the metabolites and reactions that were automatically integrated along with some 
manual curation. 
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Resumo 
A Biologia de Sistemas pretende integrar abordagens experimentais e computacionais 
com o objetivo de explicar e prever o comportamento dos organismos. O 
desenvolvimento in silico de modelos matemáticos permite atingir um conhecimento 
mais aprofundado dos seus mecanismos biológicos. Através de ferramentas 
Bioinformáticas é possível integrar uma grande quantidade de dados complexos nestes 
modelos computadorizados, assim como, realizar simulações computacionais que 
permitem prever o comportamento fenotípico dos organismos em diferentes condições 
ambientais.  
Até à data, os Modelos Metabólicos à Escala Genómica (MMEGs) incluem muitos 
componentes metabólicos de um organismo, relacionando a codificação do seu genoma 
com as suas capacidades metabólicas. Nos últimos anos, têm sido construídos vários 
MMEGs, por diferentes grupos de investigação. Com o crescente surgimento destes, 
tem-se denotado grandes falhas ao nível da padronização, uma vez que são utilizadas 
diferentes nomenclaturas por cada grupo de investigação. 
Neste trabalho, pretende-se colmatar essas falhas especificamente para os MMEGs 
humanos. Deste modo, foram selecionados os dois MMEGs humanos mais recentes, 
para passarem por um processo de integração de dados.  
As estratégias de integração das entidades mais importantes destes modelos (os 
metabolitos e as reações) foram definidas com base numa análise exaustiva dos 
modelos. O conhecimento dos atributos destes permitiu construir métodos eficientes e 
eficazes, tendo como núcleo uma base de dados desenvolvida no grupo de acolhimento.  
O resultado final deste trabalho é um repositório unificado do metabolismo humano. 
Neste, estão contidos todos os metabolitos e reações que foram integrados 
automaticamente, com alguma verificação manual. 
v 
Contents 
List of Figures vii 
List of Tables ix 
List of Acronyms xi 
1 Introduction 1 
1.1 Context ..................................................................................1 
1.2 Motivation..............................................................................3 
1.3 Objectives ..............................................................................4 
1.4 Structure of the Thesis .............................................................5 
2 Computational representations of human metabolism 6 
2.1 Metabolic Models ....................................................................7 
2.1.1 Human Genome-Scale Metabolic Models ......................9 
2.2 Metabolic Databases .............................................................12 
2.3 Metabolic Data Integration: studies and applications ..................15 
3 Graph Databases for Metabolic Data Integration 19 
3.1 Graph Databases ..................................................................19 
3.2 Neo4j ..................................................................................20 
3.3 A graph database for metabolic data integration ........................23 
3.3.1 Database Structure ...................................................24 
3.3.2 Populating the Database: ETL ....................................27 
3.3.3 Integration Algorithms ...............................................28 
3.3.4 Querying the Database ..............................................31 
Contents  vi 
 
 
 
 
4 Building a Human Metabolic Integrated Repository 33 
4.1 Implementation language .......................................................33 
4.2 Issues in the Integration of Human Metabolic Models ................34 
4.3 Local database .....................................................................35 
4.3.1 Structure .................................................................36 
4.3.2 Data Loading from SBML ..........................................39 
4.4 Integrating Human Models in the Graph Database .....................41 
4.4.1 Integrating Metabolites ..............................................41 
4.4.2 Integrating Reactions ................................................46 
5 Results 52 
5.1 Characterizing the human models ...........................................52 
5.1.1 Global characterization of the models ..........................52 
5.1.2 Examples of inconsistencies found ..............................57 
5.2 Integration results .................................................................59 
5.2.1 Metabolites ..............................................................59 
5.2.2 Reactions ................................................................64 
5.3 Analysis of a specific subsystem: the Glycolysis Pathway............67 
6 Conclusions 74 
A Results 76 
Bibliography 81 
 
 vii 
List of Figures 
Figure 2.1 - Overview of the process of a genome-scale metabolic model reconstruction 
and iterative refinement cycle. [36] ................................................................................. 8 
Figure 3.1 - Example of a query to unified database using the Neo4j Web application.22 
Figure 3.2 - Representative scheme of a part of the graph visualization, in the Neo4j 
platform. ......................................................................................................................... 25 
Figure 3.3 - Organization of unified graph database. a) Reaction schema. Each reaction 
is connected to its reactants and products (left or right). It has Name and E.C. Number. 
b) Each metabolite is composed of Name, Charge, Molecular Formula, InChI, SMILES 
(Simplified Molecular Input Line Entry System). ............................................................ 26 
Figure 4.1 - A group of species entries is transformed into a metabolite entry. Recon 2 
on the left side and HMR2.0 on the right side. .............................................................. 36 
Figure 4.2 - Metabolite’s Entity-Relationship Model. .................................................... 38 
Figure 4.3 - Reaction’s Entity-Relationship Model. ........................................................ 39 
Figure 4.4 - Example of an integrated cluster. In the square label, are represented two 
species of water, through the entry used in the HMR2.0 and Recon 2 models, 
respectively. The references in the circle (cluster) are from the BiGG, ChEBI, KEGG and 
MetaCyc databases......................................................................................................... 42 
Figure 4.5 - Representative schema of an element in SpeciesMapping. LIPID-LIPIDMAPS; 
LC-LigandCompound; LG-LigandGlycan; LD-LigandDrug. ............................................... 43 
Figure 4.6 – Example of an element of the SpeciesInReactions map. In the left side is 
double key (clusterID and stoichiometric value) and in right side are the values 
(reactionsEntry). ............................................................................................................. 47 
Figure 4.7 - Four examples of the reactions’ composition in reactionComposition map. 
The first two (of different models) are the same reaction, the same happens with the 
rest. ................................................................................................................................. 49 
List of Figures  viii 
 
 
 
 
Figure 4.8 - Explanation of the compatibility of reactions. The A, B, C and D letters 
represent the species. The reactants and the products are, respectively, the left side and 
right side of each reaction. ............................................................................................. 50 
Figure 4.9 - Representative scheme of how the inversion of the composition of a reaction 
occurs and how it becomes equivalent to another from some other model. The 
reactionEntry R_PGI and the R_HMR_4381 belong, respectively, to the 
ReactionComposition map of Recon 2 and the HMR2.0. ............................................... 50 
Figure 5.1 - Evaluation of the amount of metabolites that have references per model.
 ........................................................................................................................................ 53 
Figure 5.2 - In the Recon 2 model, 55% of the metabolites have references, and these 
are splitted in three types. ............................................................................................. 53 
Figure 5.3 - In Recon 2, each species can have more than one type of reference. In this 
Venn diagram it can be seen the amount of metabolites that are dependent of just one 
type of reference and also the ones that possess multiple references. ........................ 54 
Figure 5.4 - In the HMR2.0 model, 59% of the metabolites have references, and these 
are splitted in four types. ............................................................................................... 54 
Figure 5.5 - Type of reactions in Recon 2 and HMR2.0 models. .................................... 57 
Figure 5.6 - Examples of different metabolites that are compatible with just a metabolite 
of the other model. The first example refers to this occurrence of the HMR2.0 to the 
Recon 2, and the second is the reverse. ......................................................................... 60 
Figure 5.7 - Gains with the population of the species in unified database. The columns 
represent the number of species that were populated with references through a certain 
property. The lines are the clusterID numbers (metabolites) that were obtained (through 
the unified database), as the species were being populated. ....................................... 63 
Figure 5.8 - Representation of numeric values of metabolites found through the Clusters 
of the unified graph database versus the metabolites of the local database (originated 
from the models). In the middle are the shared metabolites. ....................................... 64 
Figure 5.9 - Representation of glycolysis subsystem. The colours dark yellow, blue and 
green, represent, respectively, the unique reactions of Recon 2, HMR2.0, and the 
reactions shared by both. ............................................................................................... 71 
 ix 
List of Tables 
Table 2.1 - Comparison of features of Recon1, Edinburgh (with compartmentalization), 
Recon 2 and HMR 2.0. .................................................................................................... 11 
Table 3.1 - Number of metabolites (first part) and reactions (second part) in the unified 
database. ........................................................................................................................ 23 
Table 3.2 - Primary properties of the metabolites. KEGG instances with Mol structures 
have computed (*) InChI and SMILES. ............................................................................ 25 
Table 3.3 – Description of the functions most commonly used to query the unified 
database. ........................................................................................................................ 32 
Table 5.1 - Global analysis of the model’s metabolites. The bottom part of the table bases 
itself only in the metabolites that do not have references (45% and 41%, in Recon 2 and 
HMR2.0, respectively). ................................................................................................... 55 
Table 5.2 - Representative table of an inconsistency situation. Specifically in the Name, 
ChEBI and Ligand Compound (LC) entities. Met_id-Metabolite_id. .............................. 58 
Table 5.3 - Representative table of an inconsistency situation. Specifically in the Name, 
ChEBI and Ligand Compound (LC) entities. Met_id-Metabolite_id. .............................. 58 
Table 5.4 - Representative table of an inconsistency situation. Specifically in the Formula 
entity. LC-LigandCompound ........................................................................................... 59 
Table 5.5 - Number of species, which through a certain property, have obtained 
references, by search method for references in Neo4j platform of the unified database.
 ........................................................................................................................................ 61 
Table 5.6 - Number of unique reactions, by method, for which there is correspondence 
in the other model. The grey columns represent the results using the reversibility. .... 65 
Table 5.7 - Number of unique reactions, by type and method, for which there is 
correspondence in the other model. The Recon2 is the grey column and the HMR2.0 is 
the white. * line with results using the reversibility. ..................................................... 66 
List of Tables  x 
 
 
 
 
Table 5.8 - Numeric results of subsystem Glycolysis...................................................... 69 
Table 5.9 - Reactions’ data (identified by a number) represented in the schema above. 
The colours dark yellow, blue and green, represent, respectively, the unique reactions 
of Recon 2, HMR2.0, and the reactions shared by both. The cofactors that are 
represented by the same order of its reactions, being “-“ the discerning element of the 
left and right sides. The entry of the reactions are abbreviated, missing the prefix (“R_” 
and “R_HMR_”). Subtitle of the compartments: C-Cytosol, R-Endoplasmic reticulum, M-
Mitochondria, X(Recon 2) -Peroxisome, P(HMR2.0)-Peroxisome. ................................. 72 
Table A.1 - Integration's result of the model's reactions from Recon 2 and HMR2.0, 
employing the direct comparison method through of the KEGG (Reaction) references 
(common element). ........................................................................................................ 76 
 
 xi 
List of Acronyms  
Ac-FAO Acylcarnitine and Fatty-Acid Oxidation 
ACID Atomicity, Consistency, Isolation, Durability 
API Application Programming Interface 
BiGG Biochemical Genetic and Genomic 
BKM-react BRENDA-KEGG-MetaCyc-reactions 
BRENDA BRaunschweig ENzyme DAtabase 
ChEBI Chemical Entities of Biological Interest 
CTS Chemical Translation Service 
DB Database  
EC  Enzyme Commission   
EHMN Edinburgh Human Metabolic Network  
ETL Extract, Transform and Load  
FBA Flux Balance Analysis 
GSMM Genome-Scale Metabolic Model 
HepatoNet1 Hepatocyte Network 1 
HMR 2.0 Human Metabolic Reaction 2.0 
HTTP HyperText Transfer Protocol 
InChI International Chemical Identifier  
JVM Java Virtual Machine 
IUBMB International Union of Biochemistry and Molecular Biology 
KEGG Kyoto Encyclopedia of Genes and Genomes 
PGDB Pathway/Genome Database 
REST REpresentational State Transfer 
List of Acronyms  xii 
 
 
 
 
SB Systems Biology 
SBML Systems Biology Markup Language  
SMILES Simplified Molecular Input Line Entry System 
SQL Structured Query Language 
XML eXtensible Markup Language 
 
 
 1 
1 Chapter 1 
Chapter 1  
Introduction  
1.1 Context 
In the last decades, different research areas, mainly Biology and Computer Sciences, 
were combined to obtain a better understanding of cellular behaviour. The combination 
of these fields with the advances in high-throughput techniques allowed the study and 
a better understanding of how cells work and react to environmental perturbations, the 
regulation of cellular processes, and even anticipate the behaviour of cells. The 
metabolism represents all chemical transformations (reactions) that occur within the 
cell, making this network one of the best characterized in Biology [1].  
Systems Biology (SB) resorts to computational tools to study cellular organisms in a 
system scope by developing models that allow in silico phenotype predictions [2].  The 
computational simulation of mathematical models allows a deeper comprehension of 
the internal nature and dynamics of cells’ processes. Thus, SB is intertwined with 
Bioinformatics, an information management discipline dedicated to biological data 
storage, processing, analysis, forecasting and modelling, relying on the use of computer 
sciences [3]. 
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In the last years, several metabolic models have been proposed to explain and study cell 
behaviour. These models, under constraint-based modelling approaches, allow the 
representation of biological knowledge in a mathematical format and the computation 
of physiological states [4-6], addressing a variety of scientific questions [7, 8]. There are 
small-scale models, which are composed by a few pathways, and genome-scale models 
that include all known components of an organism. 
Genome-scale metabolic models (GSMMs) [9] integrate physiological information and 
biochemical metabolic pathways with genome sequences. These models allow the 
interaction between subsystems, which increases the capability of phenotype prediction 
in different scenarios. Computational analysis of genome-scale metabolic models, has 
been used for biochemical [10, 11], biomedical [12-14], bioengineering [15, 16] and 
Metabolic Engineering [7] purposes. In Metabolic Engineering, the manipulation of 
metabolic models has the purpose of optimizing the genetic processes to increase the 
production of an interesting compound. One of the widely used organisms for industrial 
requirements is Escherichia coli. Several E. coli strains have been systematically designed 
to overproduce target metabolites, such as lactate, ethanol, succinate and aminoacids 
[17] through in silico analysis. 
Another application of GSMMs is in the biomedical research area, where one of the 
major tasks is to understand the relationship between metabolism and human diseases. 
Multifactorial diseases involve alterations in hundreds of genes, developmental factors 
and environmental conditions [18]. In this context, the knowledge of metabolism is 
fundamental to understand the phenotypic behaviour of cells. Thus, it is crucial to 
identify perturbed molecular mechanisms that cause such diseases to discover possible 
drug targets. The knowledge of metabolism together with individual’s genetic 
background, environmental factors and their predisposition to genetic diseases, may 
lead to personalised medicine in the near future. For all these reasons, nowadays, one 
of the biggest challenges is to be able to completely represent in silico the human 
metabolism.  To this end, human metabolic networks [19-22] have been constructed 
during the last years.  
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1.2 Motivation 
One of the steps in the reconstruction of a GSMM is the annotation of its components 
[23]. This step aims to unambiguously identify those components and provide an 
efficient mapping between the identifiers and information essential for the 
reconstruction and analysis processes. However, errors may occur in this step. The 
incomplete or incorrect annotations present in databases and available models can be 
propagated to all new reconstructions. 
In the development of human GSMMs, other problems have been detected, such as the 
non-uniqueness of metabolite identifiers across models, unbalanced atomic species 
arising from an incorrect stoichiometry or formula for one or more reactions, incorrect 
or missing cofactors, among others [24].  
The lack of usage of standards for the annotation of metabolites and reactions makes 
the comparison of different models extremely difficult. Moreover, it is natural that 
distinct databases share common records, but the lack of cross-references between 
them makes the task of achieving a consensus quite hard. In addition, each database 
focus different types of content which makes the overlap low [18]. 
In the existing protocols for genome-scale metabolic reconstruction [23], it is 
recommended to annotate metabolites with a primary identifier from at least one of the 
metabolic databases (e.g., KEGG [25]), but not all of the existing models follow this 
recommendation.  
One way to minimize models annotation problems, and reach a more complete set of 
information is to integrate several data sources, including databases and models. 
Usually, models integrate several databases through the mapping of identifiers. The 
majority of data integration applications are exclusive to chemical compounds, lacking 
the capability to integrate chemical reactions. Furthermore, the integration of GSMMs 
exposes additional complexity, since these systems incorporate additional mechanisms, 
for instance the need of gathering the information of multiple instances that represent 
the same metabolite (e.g. in multiple compartments). Integration systems are prone to 
a variety of errors such as, for example, a metabolite being associated to identifiers of 
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another metabolite. According to previous comparative evaluation of computational 
integration tools [26], it is important to establish data quality control and confidence 
scores for incoming information. In the end, a manual analysis of the data is always 
necessary. 
This work focuses in human genome-scale metabolic models. Hence, a pipeline will be 
developed that will integrate human models with the existing databases seeking to 
overcome the limitations of the available platforms. To attain an integrated GSMM of 
the human species, the laborious task of manual curation is essential, which in turn may 
provide valuable insights to improve the integration pipeline. 
The final result of this work will be a human genome-scale repository. It may be used for 
the creation of a new human GSMM, composed by curated data, which might be safely 
used for the most diverse studies and applications, especially within the biomedical 
field. In addition, this will be an important step towards the standardization and 
evolution of the human GSMMs, since the scientific community will be able to use this 
human repository as a standard to improve the models continually.    
1.3 Objectives  
The main goal of this work is to efficiently integrate existing human genome-scale 
metabolic models with a set of bioinformatics databases that include information on 
reactions and metabolites, enriching an existing data integration platform developed in 
the host group, to build an integrated, unified and global repository of human 
metabolism. 
This will encompass the following scientific/ technological objectives: 
 Review the main tools and standards within the fields of human metabolic 
modelling and data integration in this context; 
 Implement a pipeline to integrate data from human genome-scale metabolic 
models with data from metabolic-oriented databases (e.g. KEGG, MetaCyc [27]); 
 Analysis and manual curation of the previous integration result; 
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 Improve the  pipeline according to the insights provided by manual curation; 
 Build a final integrated human genome-scale repository. 
1.4 Structure of the Thesis 
The thesis is organized into six chapters. This chapter includes a short description of the 
state of the art, as well as the motivation and objectives for this work. 
The remaining chapters are organized as follows: 
Chapter 2 - Computational representations of the human metabolism 
Description of the constitution and main concepts of the metabolic models, with focus 
on the main Human Genome-Scale Metabolic Models. Likewise, existing metabolic 
database are characterized. Finally, an analysis is made to existing applications of the 
metabolic data integration. 
Chapter 3 - Graph Databases for Metabolic Data Integration 
Explanation of the structure of a graph database, in particular Neo4j and the advantages 
of its use. Then, the details of a particular database are exposed, which are used in the 
process of integrating metabolic data. 
Chapter 4 - Building a Human Metabolic Integrated Repository 
In this chapter are defined which strategies to use in the integration process and, 
consequently, the construction of a repository. 
Chapter 5 - Results 
Here, the results of the study, of the selected models for the integration process, are 
presented, as well as the obtained results with that integration. 
Chapter 6 – Conclusions 
Final considerations about the obtained results in this work, limitations and future work. 
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2 Chapter 2 
Chapter 2  
Computational representations of 
the human metabolism 
The aim of Systems Biology is to understand biological systems, studying their structure, 
dynamics, control and design methods [28], by integrating computational and 
theoretical approaches with experimental data. New knowledge in this field is being 
gathered through tools, such as automated genome annotation, genome-scale 
metabolic reconstructions and regulatory network reconstruction using microarray data 
[29]. 
Bioinformatics is an interdisciplinary field that combines computer science, statistics, 
mathematics and engineering, to develop methods and software tools for 
understanding biological data [3]. Bioinformatics and Systems Biology are rapidly 
growing fields that focus on the complex interactions in biological systems and how 
these interactions give rise to the function and behaviour of these systems.  
The huge technological advances resulted in high performance experimental 
techniques, which caused a high rate of biological data generated recently. The 
management of these data and their integration is being realized through Bioinformatics 
tools. As a result, this provides new insights to understand biological processes that 
generate new hypotheses to be tested, making it an iterative cycle. 
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2.1 Metabolic Models 
Metabolic models are reconstructed with the aim of understanding the relationship 
between the genome and the physiology of an organism/cell [9]. These comprise the 
chemical reactions of metabolism and their metabolic pathways. The main components 
of a model are the metabolic reactions, the compartments where these reactions occur, 
the metabolites that participate in those reactions, the enzymes that catalyse these 
reactions, and the genes that encode those enzymes. 
Metabolic models are complex and are based on a highly interconnected network of 
reactions and metabolites. Computational approaches are required to elucidate and 
understand metabolic genotype–phenotype relationships. Therefore, their 
reconstruction has become an indispensable tool for studying the systems biology of 
metabolism [17, 30-34]. The number of metabolic reconstructions for organisms 
increased due to the available whole genome sequences.  
The genome-scale metabolic model reconstruction process should be careful, since 
models are used to simulate the behaviour of organisms. The reconstruction process 
involves several steps such as: genome annotation; identification of the reactions from 
the annotated genome sequence and available literature; determination of the reaction 
stoichiometry; definition of subcellular compartments; assignment of localization; 
determination of the biomass composition; estimation of energy requirements, and 
definition of model constraints [9, 17, 23, 35].  
After assembling the genome scale metabolic network, there is a conversion of the 
reconstruction to a genome-scale metabolic model. The conversion is a process wherein 
the reconstruction is converted into a mathematical format, where the systems 
boundaries are defined, becoming a condition-specific model [23]. Finally, the model is 
validated and the cycle is repeated until a consensus is reached [36], as shown in Figure 
2.1. The final model could be used to perform phenotype simulations through a 
constraint based modelling approach such as Flux Balance Analysis (FBA). 
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GSMMs are commonly represented using the Systems Biology Markup Language (SBML) 
[37]. This is a software-independent language, XML-based, available in an open and free 
format. Usually, GSMMs described using SBML have the following elements: 
 Compartments: each compartment is a container where reactions take place. 
 Species: each species is a chemical substance or entity that takes part in a 
reaction. This entity mainly represents the association of a metabolite with a 
compartment, where the reaction occurs, of which the metabolite is part. Thus, 
the same metabolite can be found in different compartments, therefore existing 
multiple species for the same metabolite. The genes and other substances 
involved in reactions can also be stored as a species component. 
 Reactions: An entity describing some transformation, transport or binding 
process that can change one or more species.  
GSMMs have been applied in several studies, such as: contextualization of high-
throughput data; guidance of metabolic engineering; directing hypothesis-driven 
discovery; interrogation of multi-species relationships; and network property discovery 
[7]. 
Figure 2.1 - Overview of the process of a genome-scale metabolic model reconstruction 
and iterative refinement cycle. [36] 
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Despite the growing amount of GSMMs, the quality of annotation of those does not 
follow the same trend. One of the main reasons is the lack of an operational standard 
procedure that is followed by all research groups. This leads to many problems 
concerning the comparison of models of the same organism. A model needs to be 
reconstructed multiple times until a final version is reached being that, the more 
complex the organism, the longer the process will be. Accordingly, every reconstructed 
model (by different research groups) for the same organism is different and uses 
different biological data.  
The comparison between models is important to obtain a more complete model with all 
the available information. At the moment, this has been a laborious task, especially for 
the human organism. Since the amounts of data are huge and there is no unique 
standard for the annotation of metabolites and reactions in different models, making 
the identifiers of these entities completely different, the direct comparison is 
impossible. Thus, it is only possible to do this task in a semi-automatic procedure, using 
the unique properties of the entities, which are the markers belonging to metabolic 
databases (i.e. KEGG). Although the databases share common records, most of the times 
they do not have cross-references between them, making the task of reaching a 
consensus even harder. 
The molecular formula of the metabolites can also help in this comparison, although 
they cannot be used as single identifiers since several metabolites can have the same 
formula, but be chemically different due to the structural organization of the atoms.    
2.1.1 Human Genome-Scale Metabolic Models 
In the past years, several groups have dedicated their efforts to the reconstruction of 
human metabolic networks. From these studies, several genome-scale metabolic 
models were developed, viz. Recon 1 [19], Edinburgh [20], Recon 2 [21] and HMR 2.0 
[22] (see comparison between these models in Table 2.1) which are used as reference 
models.  
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These models have been used to explain metabolic behaviours, such as Warburg effect 
on cancer [38], to discover new targets for drugs and new biomarkers [39]. 
The Homo sapiens Recon 1  [19] was the first human genome-scale metabolic model 
fully compartmentalized. This reconstruction was based on genomic and bibliomic data. 
The manual literature-based reconstruction ensured that the network components and 
their interactions were based on direct physical evidence and reflected the knowledge 
of human metabolism. The validation of the basic functionality of this model was made 
through the in silico simulation of 288 known metabolic functions. The final model 
accounts for the functions of 1496 unique genes, 2004 proteins, 2766 metabolites, and 
3311 metabolic and transport reactions. 
The Edinburgh human metabolic network (EHMN) [20] was manually reconstructed by 
integrating genome annotation data from several databases and metabolic reaction 
information from literature. This model contains 2322 genes, 2671 metabolites, 2823 
metabolic reactions and more than 800 Enzyme Commission (EC) numbers. However, 
since 1189 transport reactions and 457 exchange reactions were not considered, due to 
the fact that subcellular location information was still not included, researchers felt that 
there was a  need to perform a compartmentalization of this model [40].  
A compartmentalization enables a better understanding of the complexity of the human 
metabolism, because the micro-environments in different organelles may lead to 
distinct functions of the same protein and the use of different enzymes for the same 
metabolic reaction. Therefore, the previous model was extended by integrating the sub-
cellular location information for the reactions, adding transport reactions and refining 
the protein-reaction relationships based on the location information. The validation of 
this “new” model was made by analysing pathways to examine the capability of the 
network to synthesize and/or degrade some key metabolites. 
The Recon 2 [21] is a consensus “metabolic re-construction”, being the most 
comprehensive representation of human metabolism that is applicable to 
computational modelling. This model combines information from EHMN, HepatoNet1 
(comprehensive reconstruction of human hepatocytes) [41], Ac-FAO [13] module (with 
acylcarnitine (AC) and fatty acid oxidation (FAO) metabolism) and the human small 
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intestinal enterocyte reconstruction with the content of Recon1. More than 370 
transport and exchange reactions were added based on a review of literature. After this, 
unambiguous third-party identifiers for cellular compartments, metabolites, enzymes 
and reactions were applied. 
The Human Metabolic Reaction 2.0 (HMR 2.0) [22] database is the largest biochemical 
reaction database for human metabolism in terms of number of 
reactions/genes/metabolites (including all of the genes, metabolites and reactions in 
the recently published models), as well as in terms of covering most parts of metabolism. 
The HMR 2.0 database was constructed using previously published genome-scale 
models and pathway databases, including KEGG, HumanCyc [42], Reactome [43] and 
LIPIDMAPS [44] Lipidomics Gateway. This was the result of the expansion of the previous 
HMR database [45] by including the lipid metabolism. Thus, it contains 59 fatty acids, 
which enable mapping and integration of lipidomics data. The resulting HMR2.0 
database contains 3765 genes, 6007 metabolites (3160 unique metabolites) and 8181 
reactions, and 74 percent of the reactions associated to one or more genes. Integration 
of extensive lipid metabolism may allow not only for the understanding of the 
contribution of lipids to the development of diseases, but also for the study of the 
relationship between lipid metabolism and cellular molecular mechanisms [46]. 
Table 2.1 - Comparison of features of Recon1, Edinburgh (with compartmentalization), 
Recon 2 and HMR 2.0. 
Number of Recon 1 Edinburgh Recon 2 HMR 2.0 
Compartments 8 9 8 9 
Metabolites (Species) 2766 3347 5063 6007 
Unique Metabolites 1509 - 2626 3160 
Genes 1501 2322 2158 3765 
Reactions 3744 6216 7440 8181 
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2.2 Metabolic Databases  
Metabolic databases are a valuable tool for the reconstruction and interpretation of 
metabolic models. These databases have detailed information about chemical entities 
and reactions, which are the primary components of these models. In the reconstruction 
of GSMMs, chemical entities can be annotated by several databases, being the most 
popular KEGG [25] and the ChEBI [47]. 
KEGG (Kyoto Encyclopedia of Genes and Genomes) is a knowledge base for systematic 
analysis of gene functions, linking genomic information with higher order functional 
information [25]. It can be seen as a computer representation of the biological system, 
where biological objects and their relationships at the molecular, cellular and organism 
levels are represented as separate database entries [48]. This integrates genomic, 
chemical and systemic functional information. Currently, it consists of 4 categories 
(Systems, Genomic, Chemical and Health information) and 17 main databases. The 
Chemical category is the most important for the comprehension of the metabolic 
models. Here, there is information related with the metabolites through the Compound 
database (which is a gathering of metabolites and other small molecules) and the Glycan 
database (that contains carbohydrates). Biochemical reactions are represented in the 
Reaction database, where the metabolites are involved as products and/or reagents. 
The reactions are connected to the enzyme databases, allowing the integration of 
genomic analysis. Thereby, through a simple search of a compound, the basic 
biochemical information, reactions and metabolic pathways in which it participates and 
even biomedical information, can be accessed. 
ChEBI (Chemical Entities of Biological Interest) is a freely available dictionary of 
molecular entities focused on “small” chemical compounds. It systematically combines 
information from various databases, which is manually annotated and curated. So, it 
focuses on high quality manual annotation, non-redundancy, and provision of a 
chemical ontology rather than full coverage of the vast chemical space. In addition to 
molecular entities, ChEBI contains groups (parts of molecular entities) and classes of 
entities. The ChEBI database also includes a chemical ontology, which allows the 
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relationships between molecular entities or classes of entities and their parents and/or 
children to be specified in a structured way [47].  Thus, ChEBI provides detailed chemical 
data about compounds, which is important for the study of chemical interactions that 
occur within a cell.  
Both databases attempt to supply cross-references between themselves and also for 
other databases. Despite the importance of these databases, for the study and 
integration of the existing GSMMs, there are also another databases that could be used 
to extend and improve the annotation of models entities. 
BRENDA (BRaunschweig ENzyme DAtabase) is a collection of enzyme functional and 
molecular data [49]. It represents a comprehensive database containing all enzymes 
classified according to the EC classification system of the IUBMB [50] (International 
Union of Biochemistry and Molecular Biology). BRENDA contains information on all 
classified enzymes of organisms of all taxonomic groups.  
The information is extracted from primary literature and manually curated. Each entry 
is linked to a literature reference and to the source organism. Additionally, BRENDA can 
provide large amounts of information as the existence of enzymes in organisms, their 
cellular localization, their involvement in human diseases, their active centers and 
interfaces and additional kinetic data. In summary, BRENDA stands out for not being 
limited to a specific aspect of the enzyme or to a specific organism. 
BioCyc collection of Pathway/Genome Databases (PGDBs) provides electronic reference 
sources on the pathways and genomes of many organisms [51]. PGDBs provide genomic 
information with an extensive dimension that allows researchers to analyse the 
relationship between organism's genome and metabolic network. BioCyc is primarily 
microbial, but contains databases for humans and for important model organisms. 
Consequently, it allows comparative analysis, since multiple PGDBs are available within 
one place. BioCyc organizes its databases in tiers, according to the amount of manual 
curation and update they received.  
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Within BioCyc, the most relevant databases for the reconstruction and integration of 
GSMMs are HumanCyc and MetaCyc that are in tier one, which means that these have 
been created through intensive manual efforts and get continuously updated. 
MetaCyc is a non-redundant reference database, of small-molecule metabolism that 
contains experimentally verified metabolic pathways and enzyme information [52]. 
MetaCyc contains pathways involved in the primary and secondary metabolisms, as well 
as associated metabolites, reactions, enzymes and genes. The MetaCyc goal is to catalog 
the metabolism universe, storing a representative sample of each of the pathways 
experimentally elucidated. Once that MetaCyc is based in experimentally elucidated and 
verified data only, it becomes a valuable asset for the study of the models metabolic 
pathways. 
HumanCyc is a database of enzymatic reactions and human metabolic pathways [42]. 
The aforementioned is a PGDB for Homo sapiens, from the annotated human genome. 
It provides an expandable human metabolic map diagram, and it has been used to 
generate a steady-state quantitative model of human metabolism. HumanCyc positions 
human genes in a pathway context thereby facilitating analysis of gene expression, 
proteomics, and metabolomics datasets. Although HumanCyc is considered a curated 
database, it is not yet completely verified. Thus, despite having a helpful use, specifically 
in the human models, it must be cautiously used. 
As reported, there are several databases with different purposes. The diversity and 
amount of information in databases allows to structure the knowledge to become more 
usable. However, since there are many available data in different databases, some 
problems regarding redundancy and inconsistency between them, can occur. The 
majority of the databases comprise cross-references between their data, but 
nonetheless it is possible to find incoherent information in considerable amounts. 
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2.3 Metabolic Data Integration: studies and 
applications  
In Stobbe et al. [18], the comparison of five databases  (EHMN, Recon 1, HumanCyc, 
Reactome  and the metabolic subsets of KEGG) and their analysis showed that only a 
small core of metabolic network coexists in all five databases. In particular, in the case 
of reactions, the overlap is quite low, since only 199 reactions can be found in all five 
databases. This occurrence is partially due to conceptual differences in the databases, 
like, for instance, in EHMN, where 23 percent of unique reactions are transport reactions 
and reactions in lipid metabolism. Knowing that one of the main reasons for the lack of 
overlap is the difference of content, not only the syntax, each one of the five pathway 
databases provides a valuable piece of the puzzle. This inability to directly make use of 
metabolite/reaction information from biological databases or other models, due to 
incompatibilities of representation, duplications and errors, is an obstacle for the 
reconstruction of new high quality metabolic models. 
One of the purposes of information integration is the reconciliation of heterogeneous 
data sources to obtain a non-redundant, non-ambiguous and complete information 
system. The integration of heterogeneous data sources significantly enhances the 
quality of a reconstruction that eventually improves the quality standards. Thus, the 
reconciliation of metabolites and reactions is an essential step in the development of 
comprehensive metabolic models. 
In order to fill the existing gaps in the databases and specially the lack of standards for 
the identifiers, applications that integrate multiple available resources have been 
created. This can ease, for instance, the process of automatically updating the 
annotations of GSMMs. Here, three open-source applications will be described that do 
the mapping between available metabolite identifiers. 
MetMask [53] (the metabolite masking tool) is an application that integrates reference 
chemical libraries and external public databases, building from these a local database 
that contains groups of identifiers. The primary identifiers and their connections with 
other public databases are extracted from the external databases. The collected data is 
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used to merge groups that are considered compatible by the heuristics implemented in 
the application. These heuristics include the use of rules that restrict the inclusion of 
identifiers in the group, depending for instance, if this is coming from the same source. 
This application allows to import other data, which can increase the accuracy of the 
merge. The result of the search by identifier can be seen in a graph format. 
The Chemical Translation Service [54] (CTS) is a web-based tool to map identical 
chemical identifiers. It aggregates multiple external sources in a single database where 
the main identifier is the International Chemical Identifier (InChI) code Hash Key. The 
InChI is a textual identifier to define a chemical substances and it can encode molecular 
information, including structural data. Depending on the chemical molecule, the InChI 
can reach thousands of characters; this eventually is a problem for database searching. 
Additionally, an InChI contains non-alphanumeric characters, which may also be another 
problem for certain searching engines. To overcome this problem, the InChIKey is a 
twenty-seven-character code generated from the InChI hash algorithm that contains 
only regular characters; this identifier eases the search of information within databases. 
This tool finds all standard InChIKeys that are linked to an input identifier and returns all 
identifiers of the requested output type(s) that are linked to the same standard 
InChIKeys. The CTS consists in three major services: the Discovery Service (detects 
chemicals); the Convert Service (interconverts any chemical identifier into other 
chemical identifiers); the Batch Convert Service (converts multiple identifiers of the 
same type into multiple identifiers). This application is very useful, for instance, to detect 
doublets. 
UniChem [55] is a  web application available for free, for compound identifier mapping. 
It was designed to optimize the efficiency with which structure-based hyperlinks may be 
built and maintained between chemistry-based resources. It has some characteristics in 
common with the previous application (CTS) since it is also based on standard InChIs and 
InChIKeys to make the match of the identifiers. Furthermore, multiple external 
databases are also aggregated in a single database, where the queries are sent. In this 
case, before being integrated, the external databases go through quality tests, where, 
for instance, it is verified if an InChI pattern of an entry can be converted into an InChIKey 
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pattern. Moreover, UniChem preserves which database identifiers are associated with 
a certain InChI identifier [26]. 
The main purpose of these applications is to provide a tool to support the mapping of 
metabolite identifiers between distinct sources, which is a valuable utility in metabolic 
network reconstruction projects. Most of these tools cover a large set of the identifiers, 
although there is a poor match among databases.  
The InChI based applications were considered the best approach for the mapping [26]. 
In particular, CTS showed a better capability to map identifiers. Despite this, the task to 
annotate these identifiers still remains laborious, since the automatic updating of the 
metabolite identifiers in metabolic network reconstructions is not yet possible. Although 
these applications help supplement information relating to metabolites, it is not 
sufficient for a complete and correct unification of all of the information present in a 
GSMM. A more sophisticated pipeline for the integration of metabolites and 
biochemical reactions still remains a challenge. 
Parallel to these tools there are also a few databases that integrate several metabolic 
sources. The BKM-react (BRENDA-KEGG-MetaCyc-reactions) [56] is a comprehensive 
non-redundant biochemical reaction database containing both enzyme-catalysed and 
spontaneous reactions. Biochemical reactions collected from BRENDA, KEGG and 
MetaCyc were matched and integrated by aligning substrates and products. The 
reaction comparisons follow two steps: the comparison of reactant structures using 
InChIs and the compound name comparison (including synonyms). The result of a query 
is the display of all aligned reactions for all databases in comparison. BKM-react can 
significantly facilitate and accelerate the construction of accurate biochemical models. 
MetaNetX is a user-friendly and self-explanatory website for accessing, analysing and 
manipulating GSMMs as well as biochemical pathways [57]. It consistently integrates 
data from various public resources (models, metabolic pathways, etc.) in a single 
repository. All repository or user uploaded models are automatically reconciled in a 
common namespace defined by MNXref [58]. MNXref uses information on cellular 
compartments, reactions, and metabolites that is sourced from a number of external 
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resources.  Consequently, for each entity mentioned, it indicates which external 
resource provided the information used in MNXref.  
MetaNetX, which allows an exhaustive analysis of any model, is a user-friendly tool that 
can be useful when establishing a comparison between models. In addition, two or more 
GSMMs or pathways can be compared to determine shared parts. It is also possible to 
create new models based on the analysis and modification of existing models. For 
instance, MetaNetX can be used to increase/update a model. Information concerning 
the models, as well as results of analyses performed on them, is provided in the form of 
tables. 
MetRxn [59] is a knowledge base that includes standardized metabolite and reaction 
descriptions by integrating information from databases and genome-scale metabolic 
models into a single unified data set. This approach is identical to the aforementioned 
MetaNetX, however the methods used are different, which leads to different results. 
For instance, while MNXref provides a single reconciliation based on heuristic merging 
of stereoisomers, MetRxn provides two reconciliations in which stereoisomers are 
considered separately or as a single entity [58]. This affects, for instance, the final 
number of unique reactions. Furthermore, the MetRxn is much more limited in terms of 
analysis and comparison of the models.    
Among these, the MetaNetX reveals itself, at the moment, as the best tool for the study 
and comparison of models. 
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3 Chapter 3 
Chapter 3  
Graph Databases for Metabolic Data 
Integration 
This work emerged from the urgent need to create tools with the capability to compare 
metabolic models, with the focus on human GSMMs. The integration of these models 
implies a detailed examination of the components found in these models (i.e., species, 
reactions, etc.). Therefore, it is necessary to integrate existing databases of biochemical 
information with the human GSMMs. This will provide a more detailed information for 
the entities, to clarify cases of ambiguity and to standardize the annotation. In order to 
assist this integration, an approach based in graph databases is used. This chapter briefly 
describes graph databases and their use for metabolic data integration, in a tool 
previously developed in the host research group.       
3.1 Graph Databases 
Graph databases are based on graph structures. A graph is defined as a set of vertices 
(or nodes) and a set of edges (or relationships) connecting the vertices. The edges can 
be directed or undirected depending of the type of graphs. To summarise, a graph 
system allows to show how certain entities are related. 
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Connected entities (or nodes) are contained within a graph database, each of which is 
constituted by a set of outgoing edges and / or incoming edges and a set of properties 
(key-value-pairs), where one of them is a unique identifier. These nodes can be labelled 
with one or more labels that identify its role in context.  In turn, a relationship (or edge) 
has two nodes (a start node and an end node), a direction, a type, and can also have a 
set of properties. 
The use of a graph database may be advantageous versus a relational database, since it 
is not necessary to make an extensive entity-relationship study of the domain to define 
a database schema. Because, in graph databases, anything can connect to anything, 
future changes can be easily applied. This flexibility also means fewer migrations. 
Furthermore, in certain types of operations (e.g., extensive and recursive join 
operations) they are much faster [60], allowing to scale with large data sets more 
naturally, given that only part of the graph is traversed to obtain the result of a query. 
Thus, when querying highly related data, a graph database can be many folds faster than 
a relational database.  
Graph databases engines also operate with Create, Read, Update, and Delete operations 
(CRUD). Some databases are able to operate under non-native engine (i.e., third party 
storage engines). However, with the use of the non-native graph storage, the graph 
database becomes a query mediator that translates graph query languages to the non-
native storage engine. In these cases, the query engines have to make more 
computational effort. This happens because non-native graph storage typically depends 
on a mature non-graph backend (such as MySQL), while native graph storage is 
optimized and designed for storing and managing graphs. 
3.2 Neo4j 
Neo4j [61] is an open-source NoSQL graph database implemented in Java and Scala. It is 
a high performance graph store with all the features expected from a mature and robust 
database, such as, with a proper query language and ACID (Atomicity, Consistency, 
Isolation, and Durability) transactions. Through atomicity, it is guaranteed that, if a 
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transaction fails, the database remains unchanged. Changes made in the database have 
to respect its integrity, thus maintaining consistency. The isolation of the parallel 
transactions prevents transactions from interfering with each other. The results of a 
committed transaction stay available permanently, thus making graph databases 
durable and is quite reliable.  
Neo4j provides native graph storage that enables its engine to perform native graph 
processing. Therefore, defining the relationships at runtime time have minimal impact 
in the performance of the queries. 
Cypher is a declarative graph query language, specific to Neo4j. It is focused in the clarity 
of their queries, being its language based on iconography and English prose. Although it 
is a simple language, it is nonetheless powerful, allowing both simple and complex 
queries to be easily expressed. Knowing that "( )" represent the nodes and "[ ]" the 
relationships, it is easy, at a first sight, to write and interpret a relatively easy query. This 
proximity with graphical representation makes it extremely intuitive. 
Neo4j is implemented on top of the JVM (Java Virtual Machine), and can be easily 
accessed by either a RESTful1 HTTP2 API3 or Java API. It has support for several other 
programming languages (e.g., python, ruby, etc.) and platforms (e.g., node.js), not being 
required for the user to have an extensive knowledge of the server and the resources it 
hosts in advance.  
 
                                                     
1 REpresentational State Transfer 
2 Hypertext Transfer Protocol 
3 Application Programming Interface 
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Furthermore, it is also possible to query and visualize the data (example in Figure 3.1), 
through a Web application (the Neo4j Browser). Here, the graph can be visually 
explored, providing the possibility to see properties of the entities by a simple click on a 
node or a relationship. It is also possible to expand connected nodes with the interface. 
This graph visualization tool provided by the database allows a more intuitive perception 
and analysis of the data. All these features enable the development and analysis of big 
network structures. 
 
In the Neo4j graph database, as expected, each graph is constituted by many nodes that 
can be related unidirectionally. It is mandatory that each node has a label that says what 
it represents. Moreover, Neo4j allows the addition of more than one label to a node, 
since this can fulfil several different roles. Using labels it is possible to bundle nodes, 
which facilitates the queries. The relationships can also have labels that tell which way 
a certain node can relate with another. Both nodes and relationships may be established 
by properties that are, just as it sounds, the properties of the node, meaning that they 
keep the relevant information about every node.  
Figure 3.1 - Example of a query to unified database using the Neo4j Web application. 
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3.3 A graph database for metabolic data 
integration 
As a basis for this work, an existing metabolic data integration system was used to aid 
the integration tasks (http://darwin.di.uminho.pt/biodb/). This system loaded 
information from several databases of compounds and reactions in a single unified 
Neo4j graph database (Table 3.1). This database is the central storage to catalogue 
biochemical entities for analysis and integration purposes. Parallel to this database, it 
also provides an integrated database that integrates the instances from the central 
storage based on several rules and axioms. 
 
Table 3.1 - Number of metabolites (first part) and reactions (second part) in the unified 
database. 
Database Records Version 
KEGG (Compound) 17909 Release 68.0 (October 1, 2013) 
KEGG (Glycan) 10988 Release 68.0 (October 1, 2013) 
KEGG (Drug) 10126 Release 68.0 (October 1, 2013) 
MetaCyc 15983 Release 17.5 
BiGG 2835 Schellenberger et al. (2010) 
SEED 16996 Aziz et al. (2013) 
ChEBI 81231 Release 110  (December 2, 2013) 
KEGG 9886 Release 68.0 (October 1, 2013) 
MetaCyc 12264 Release 17.5 
BiGG 7135 Schellenberger et al. (2010) 
SEED 13246 Aziz et al. (2013) 
 
The system has two levels: a first level loads information from each data source in a 
unified resource. The second level, the integrated database fuses instances from the 
unified database by creating clusters of metabolic instances. These instances are 
potential compounds or reactions that are considered as equivalent (i.e., the same 
molecule or the same reaction). 
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Since it is a Neo4j database, it is possible to query and visualize the data from the Web 
platform. This feature is very useful because it allows an intuitive analysis of the 
references of the properties connected among species. When a species is missing a 
reference, it is necessary to find at least one reference to identify it. In this graph 
database, each instance of a compound of a biochemical database (e.g., KEGG, MetaCyc, 
etc.) is a distinct node. These nodes are connected by their related properties, as well as 
other identifiers from other databases. Therefore, it is possible to traverse the graph 
through the properties (of a specie) to identify the references that are related to each 
other. 
3.3.1 Database Structure 
The unified schema is similar to an ontology, with entities, classes and relationships. 
Ontologies allow for organizing and giving structure to information, enabling computers 
to reason about the data. The objects in an ontology are characterized by a class 
hierarchy and are related to each other by relationships. This relationship usually follows 
the subject-predicate-object triple (e.g., CoA has_formula C21H36N7O16P3S). 
The Metabolite and the Reaction are the top classes of the database, since they are the 
core entities of this domain (Figure 3.3). Then, they are extended by several sub-classes, 
that are specific to other biochemical database instances (e.g., <Metabolite, ChEBI>, 
<Metabolite, LigandCompoud>, etc.). Both Reaction and Compound are considered an 
entity class. 
The primary attributes (Table 3.2) are represented as property classes (e.g., Molecular 
Formula, Name, InChI, etc.). However, due to the diversity of properties between 
instances, lesser popular attributes are considered secondary properties, and these are 
stored as attributes of the entities. 
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Table 3.2 - Primary properties of the metabolites. KEGG instances with Mol structures 
have computed (*) InChI and SMILES. 
 
Finally, a set of relationships is declared to specify how classes interact between each 
other (Figure 3.2). Among the variety of possible relationships, the most relevant is the 
property attribution with the relationship has_<property name> that connects an 
entity object with a property object. Related entities may also be connected with each 
other with the has_crossreference relationship. This relationship usually indicates 
that they are strong candidates for entity fusion. Apart from the identity relationship, 
the hierarchy between compounds is established with instance_of/super 
relationship (e.g., META:ETOH instanse_of META:Primary-Alcohols). Finally, 
reaction entities are related to metabolites with the left/right relationship to 
describe stoichiometry. 
 Synonyms Formula Charge Mol InChI SMILES 
KEGG (Compound) Yes Yes No Yes No * No * 
KEGG (Glycan) Yes Yes No No No No 
KEGG (Drug) Yes Yes No Yes No * No * 
MetaCyc Yes Yes Yes No Yes Yes 
BiGG No Yes Yes No No No 
SEED Yes Yes Yes No No No 
ChEBI Yes Yes Yes Yes Yes Yes 
ChEBI 
Formula 
Name 
InChI 
KEGG 
has_name has_crossreference_to 
Figure 3.2 - Representative scheme of a part of the graph visualization, in the Neo4j 
platform. 
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In the Neo4j graph environment, the classes are nodes, while relationships are edges 
between nodes, this implies that nodes are both properties (i.e., names, formulas, etc.) 
and entities (i.e., a specific KEGG compound, a reaction). 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 - Organization of unified graph database. a) Reaction schema. Each reaction 
is connected to its reactants and products (left or right). It has Name and E.C. Number. 
b) Each metabolite is composed of Name, Charge, Molecular Formula, InChI, SMILES 
(Simplified Molecular Input Line Entry System). 
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3.3.2 Populating the Database: ETL  
The unified graph database is populated by a pipeline similar to other Extract, Transform 
and Load (ETL) systems. An ETL tool is based on three core tasks:  
 Extract, where in a set of heterogeneous data sources (i.e. KEGG, ChEBI, BiGG 
[62], etc.) are loaded. The main role of this task is to read the data from the 
source and convert into a standard format. This is highly dependent on the type 
of data source. 
 Transform, where the transformation of those data, for the structure that unifies 
them (unification schema), occurs. The transformation task converts to the 
graph data format. This involves identification of the classes and relationships 
required by the instance to be loaded into the unified database. 
 Load, where the data is loaded into the unified database. 
Besides these three stages, to secure a robust ETL pipeline, it is necessary to 
complement it with several additional subsystems. These subsystems are related to a 
variety of tasks that are relevant to an integration system, such as logging, backup, 
quality check and many more. Within these roles, a few were chosen to be implemented 
based on their relevance to solve the inherent problem. A quality screening handler is 
based on systematically applied tests to checking of issues regarding to the quality of 
data. These can be invalid descriptors of attributes such as invalid chemical formulas, 
unidentified references. Within this data context, molecular formulas must be subject 
to a normalization process (since equal molecular formulas can be written in different 
ways, e.g. CHO, C1H1O1, and OCH).  
The addition of a new data source involves an analysis of the data type, made by the 
data profiling system.  This analysis assists the data conformer in the purpose of 
“translating” data to a unified version. 
In addition to these subsystems, an ETL system requires a data storage system in which 
it serves as an intermediate store to support the process. Depending of the 
heterogeneity of the sources, the design process of this component is usually time 
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consuming and prone to future changes. Graph database entities are represented by 
generic vertices annotated by properties to provide some identity to these. Then, 
relationships are created by connecting these vertices with edges. Therefore, it is 
possible to represent a flexible schema since everything can relate to anything.  
3.3.3 Integration Algorithms  
The metabolites of the global database were integrated based on their properties and 
attributes. The selection of these was based on the necessity and the scope. Take, for 
instance, the InChI property which is commonly referred in the literature as the best 
descriptor for biochemical molecules, due to its unique and unambiguous 
representation. However, integration with InChI will only apply to a few molecules that 
have an InChI descriptor. Thus, other properties less viable are needed to increase the 
scope. 
The InChI Key is used to discard the protonation state of the molecules. The InChI Key is 
a 25 letter hash key (XXXXXXXXXXXXXX-YYYYYYYYFV-P), having the first block of 14 
letters to encode the structure of the molecule, the second block to encode the stereo 
structure and last three characters to encode meta information, the standard InChI flag, 
the version, and lastly the protonation. By discarding the last character that encodes 
protonation, it is possible to capture molecules independent of their protonation state. 
A limitation to this strategy is that unlike InChI the InChI Key is not unique, however this 
happens only in rare occasions were hash collisions occur. 
Important properties are the ChEBI parent relationships. Some ChEBI entities are related 
to each other by a chebi_parent relationship. This, allows to fuse internal replicas among 
ChEBI instances. The KEGG remark attribute is also used. In many cases the remark 
attribute of KEGG instances has a “Same as:” notification (e.g., Same as: C06217). The 
integration exploits this attribute to recover a few entities that are replicas between the 
KEGG Compound, Glycan and Drug databases. 
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The cross-references were also used since many compounds lack proper descriptors to 
determine the identity of the metabolites. Also, the cross-referencing is in fact the 
largest contributor to resolve metabolites. 
Each of the methods generates an independent set of metabolite clusters, and later 
after evaluation, they are merged together to create the master integration set. To 
summarize, five methods were combined together: the InChI, the InChIKey, ChEBI 
parent references, KEGG remark attribute, and cross-references. A total of 22.001 
metabolite clusters were created using those strategies. 
While the reconciliation of metabolites relies essentially on the attributes (e.g., chemical 
structures, names, molecular formula), the reaction instances offers a very limited set 
attributes. 
Some databases have a name for certain reactions, usually a popular name, but perhaps 
the most relevant attribute related to reactions is the Enzyme Commission Number (EC). 
A problem of this classification method is the ambiguity of a few numbers, as example 
the EC 1.1.1.1 which represents the role of an alcohol dehydrogenase is valid for every 
reaction that acts on a primary alcohol to produce an aldehyde, a simple query with this 
EC number in KEGG would result in several reactions. Therefore, a single EC number may 
span to multiple stoichiometry. 
The integration of reactions relies on a different method. The comparison of the 
stoichiometry between reactions allows precisely to identify replicas among reaction 
instances. 
As an example, the following reactions from KEGG and MetaCyc: 
 𝑟1 ∶ 𝐶00631 ↔ 𝐶00074 + 𝐶00001  ( 3.1 ) 
 𝑟2 : 2 −  𝑃𝐺 ↔ 𝑃𝐻𝑂𝑆𝑃𝐻𝑂 − 𝐸𝑁𝑂𝐿 − 𝑃𝑌𝑅𝑈𝑉𝐴𝑇𝐸 + 𝑊𝐴𝑇𝐸𝑅  ( 3.2 ) 
 
The identity of the species plays an important role in the identity of the reactions. If 
species in the first reaction are equal to the ones in the second, then the two reactions 
can be safely assumed as identical. 
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However, there are some aspects about the stoichiometry of the reaction that must be 
taken into account. The protonation state of the species in the stoichiometry changes 
the number of hydrogen atoms in their molecular formula. This implies to balance the 
stoichiometry with the addition of hydrogen molecules. But since on the metabolite 
integration method it was assumed that the protonation state is not relevant for the 
metabolite identity, in the case of reactions this should also be true. 
𝑟3 ∶ 𝐶00002 +  𝐶00022 ↔ 𝐶00008 + 𝐶00074  ( 3.3 ) 
𝑟4 : 𝐴𝑇𝑃 + 𝑃𝑌𝑅𝑈𝑉𝐴𝑇𝐸 ↔ 𝐴𝐷𝑃 + 𝑃𝐻𝑂𝑆𝑃𝐻𝑂 − 𝐸𝑁𝑂𝐿 − 𝑃𝑌𝑅𝑈𝑉𝐴𝑇𝐸 + 𝑃𝑅𝑂𝑇𝑂𝑁  ( 3.4 ) 
 
This can be done by ignoring the hydrogen molecule in the stoichiometry, which is a 
common practice in many integration platforms. The direction of the reaction also plays 
a role in the stoichiometry of the reaction. As aforementioned in the domain 
relationships, a reaction has left_component and right_component these are the left 
and right side of the stoichiometric equation. However, the left and right it is not related 
to any orientation. Given for example, the MetaCyc has examples of reactions with 
direction marked as RIGHT-TO-LEFT. It would be convenient to normalize the direction 
by inverting the stoichiometry of these cases. However, since the direction of reactions 
is not easy to define as they are dependent on several variables (e.g., enzyme regulation, 
concentration of species, etc.), most databases do not specify any direction for their 
reactions, leaving the judgement to the user. 
The reaction integration algorithm (Algorithm 1) takes the stoichiometry of the reactions 
and performs mapping substitutions to the integrated species. As an example, in 
reactions ( 3.1 ) and ( 3.2 ) assuming every species is correctly integrated, substitution 
of the original species would result in identical stoichiometry, thus the returning 
stoichiometry dictionary would be [ [𝑐𝑎 ↔ 𝑐𝑏 + 𝑐𝑐] → 〈𝑟1, 𝑟2〉] (previous species were 
replaced by 𝑐𝑎, 𝑐𝑏 , 𝑐𝑐).  
The 𝑃 set controls species to ignore, since the species found in 𝑃 are ignored from the 
stoichiometry. This allows to remove the proton species from reactions (Algorithm 1, 
line 11). 
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3.3.4 Querying the Database 
The integration platform provides a REST API to interact with the system. This API allows 
both queries and modifications in the integration. Together with the REST API, a Java 
interface is also provided. 
Currently, REST APIs are common within online services due to their simplicity. These 
APIs rely on HTTP verbs (i.e., GET, POST, PUT, DELETE) to perform operations (Table 3.3), 
that mimic the CRUD operations of database engines.  
The database is also available for download, allowing to run the database embedded 
with Java applications eliminating the delay for network communication. 
 
Algorithm 1: Reaction Stoichiometry Unification 
 
 
 
1:  
2:  
3:  
4:  
5:  
6:  
7:  
8:  
9:  
10:  
11:  
12:  
 
13:  
14:  
15:  
16:  
17:  
18:  
 𝐈𝐧𝐩𝐮𝐭: 𝑈 a unification map, 𝑅 a set of reactions, 𝑃 a set of metabolites to  
ignore  
𝐎𝐮𝐭𝐩𝐮𝐭: 𝑆 a dictionary with reactions grouped by stoichiometry   
𝐩𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐞 ReactionIntegration(𝑈, 𝑅, 𝑃)  
𝑆[𝑠] = {}      ⇒ Initialize empty dictionary 
𝐟𝐨𝐫 𝑟 ∈  𝑅 𝐝𝐨  
       𝑠 = {}            ⇒ Initialize empty stoichiometry 
       𝐟𝐨𝐫 〈𝑚, 𝑖〉 ∈ 𝑟 𝐝𝐨 
             𝐢𝐟 𝑈[𝑚] 𝐭𝐡𝐞𝐧 
                  𝑐 ← 𝑈[𝑚] 
             𝐞𝐥𝐬𝐞 
                  𝑐 ← 𝑚 
             𝐞𝐧𝐝 𝐢𝐟  
             𝐢𝐟  𝑚 ∉ 𝑃 or 𝑐 ∉ 𝑃 𝐭𝐡𝐞𝐧          ⇒ Test if to ignore species 
                   𝑠[𝑐] ← {
1         if 𝑖 ≥ 0
−1      if 𝑖 < 0
  
             𝐞𝐧𝐝 𝐢𝐟 
         𝐞𝐧𝐝 𝐟𝐨𝐫 
         Add 𝑟 to 𝑆[𝑠] 
𝐞𝐧𝐝 𝐟𝐨𝐫  
𝐫𝐞𝐭𝐮𝐫𝐧 𝑆  
𝐞𝐧𝐝 𝐩𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐞  
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Table 3.3 – Description of the functions most commonly used to query the unified 
database. 
Below, there is a description of the functions from Table 3.3: 
1. Get the entity ModelSpecies, through the parameters model’s name and 
speciesEntry. 
2. Get a list of entity ModelReaction, through the parameter model’s name. 
3. Upload the SpeciesModel with references, through the parameters model’s 
name and file. 
4. Get the integration map, through the parameter ID of reference. 
 
 
 
 Functions Method Path Variable Parameter 
1.  
/metabolic/model/mmd/{model}/spi/
{id} GET 
model 
- 
id 
2.  /metabolic/model/mmd/{model}/rxn GET model - 
3.  
/metabolic/model/mmd/{model}/spi/
ref/upload POST model file 
4.  
/integration/explore/cpd/findByRe
ferenceId GET - referenceid 
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4 Chapter 4 
Chapter 4  
Building a Human Metabolic 
Integrated Repository  
The human GSSMs are models that are complex and difficult to integrate, thus, it is 
necessary to detain a broad knowledge about these, so that more efficient strategies 
can be defined, to execute that task and also be able to construct a Human Metabolic 
Integrated quality repository. In this chapter, the methods created for the metabolites 
and reactions' integration process, are described. 
4.1 Implementation language 
The framework developed in this work was implemented in Java language programming 
[64], making use of its main features, such as, the object-oriented patterns, the 
portability and a library (known as  Application Programming Interface, API) with a wide 
range of packages [65]. Furthermore, this language allows an easy interaction with SQL 
server database and Neo4j server. 
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4.2 Issues in the Integration of Human 
Metabolic Models 
Even though the SBML files of the human GSMMs follow mostly a standard format, most 
of the existing content does not follow that premise. This way, it is mandatory to follow 
strategies that lead to a consistent comparison between them. In order to design these 
strategies, there is the need to analyse the content of each used GSMM. 
When intending to make a comparison between files it is crucial that the amount of data 
presented is similar in each one. As for the human GSMMs, the Compartment, Species 
and Reaction entities in particular must have an identical number of specimens. This fact 
is very important, since if there is a large differential at this level, there will be more 
variability between the models' data and, as a consequence, fewer parts in common. 
Taking it into account (as it was verified in the aforementioned Table 2.1) and also the 
fact that they are the most recent, the Recon 2 and HMR2.0 models were the ones 
selected for the execution of this work. 
The main strategy for enabling a comparison of the models is to use the properties 
present in the non-redundant and inconsistent entities. Specifically, for the human 
GSMMs, the data that is normally present and that follows that principle are the 
references to the available external databases. These references are present in the 
annotations of the Metabolites (Species) entities. Therefore, if two metabolites of 
different models are annotated with the same reference, one can say, with a great 
amount of certainty that they are the same, but it cannot be completely certain upfront, 
since there can be cases where the metabolites were wrongly annotated, misleading 
these direct comparisons. 
Although the existence of references is common in current models, there is a major gap 
at this level, making the comparison task difficult. Besides the existing gap regarding the 
coverage of metabolites essential to this information, there is also a lack of agreement 
on the types of used references, so it is frequent to have two metabolites in different 
models, which are the same, but that are not directly identified as such. An example of 
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that, is when a metabolite is annotated with a reference to the KEGG database and with 
another for ChEBI.  
Some of the aforementioned problems can be solved by the adequate usage of the 
species’ properties. However, it is necessary that the properties used within the search 
are trustworthy. Ideally, only the unique characteristics such as InChI should be used. 
However, the presence of such properties in human GSMMs is not very wide, so it is 
necessary to use other resources.  
The reactions contained in human GSMMs do not have unique properties that can 
identify them easily. Therefore, the only way to integrate reactions is through the 
comparison of their species (metabolites-associated compartments) that bring up 
different kinds of problems, associated with metabolites’ data that are not yet fully 
integrated. In addition, this task stumbles upon other problems such as the reversibility, 
the different balancing equations and the different cofactors of the reactions.  
Other than that, each reaction belongs to a subsystem, with whom it is annotated. 
Sometimes equivalent reactions are located in different subsystems. This brings into 
question the integration, being mandatory to understand in which manner are the 
subsystems organized. A subsystem is a metabolic pathway that represents a series of 
chemical reactions occurring within a cell. The initial metabolite is typically modified by 
a sequence of chemical reactions until arriving to a final product. Bearing all that in mind, 
the study of subsystems contained in the Recon 2 and HMR 2.0 GSMMs allows for a 
better understanding of the real differences of content among these. 
4.3 Local database  
In order to organize the content and to ease its analysis, a local database was created. 
This database received only the data from Recon 2 and HMR 2.0. Therefore, an intensive 
study of the data can be accomplished, leading to a clarification of potential strategies 
capable of being used for the integration of GSMMs. In addition, possible errors were 
pursued and, whenever possible, rectified. 
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The local database is a related database written in the SQL language. This allows an easy 
interaction between Java and the MySQL server. Besides, the tables’ visualization in 
MySQL enables a fast and effective manual error detection.     
4.3.1 Structure 
The local database has as entities the Metabolite, MetaboliteXref, Compartment, 
Species, SpecieXref, Reaction, ReactionRight and ReactionLeft. Each of these entities has 
many attributes: 
 ID: the unique and primary key of all entities. It is a number generated 
automatically;  
 Name; 
 Entry: the unique key present in each model. In the Metabolite entity this 
property is altered. Each element takes on the entry of its species, without the 
suffix refering to the compartment (Figure 4.1); 
 
 
 Source: identify the origin of the element (e.g. Recon 2 or HMR 2.0).  
 
 
M_h2o_e 
M_h2o_c 
M_h2o_x 
M_h2o_l 
M_h2o_m 
M_h2o_g 
M_h2o_r 
M_h2o_n 
M_h2o_ 
M_m02040x
M_m02040s 
M_m02040c
M_m02040p
M_m02040l
M_m02040m
M_m02040g 
M_m02040r
M_m02040n 
M_m02040 
Figure 4.1 - A group of species entries is transformed into a metabolite entry. Recon 2 
on the left side and HMR2.0 on the right side. 
Chapter 4: Building a Human Metabolic Integrated Repository 37 
 
 
 
 
Metabolite-only attributes: 
 MCLASS: abbreviation of metabolite class. In this case, all of them are 
compounds. 
Species-only attributes: 
 InChI: textual identifier to define chemical substances; 
 Formula: the expression that describes the composition of the compound; 
 Charge: the net charge is the arithmetic sum of positive and negative charges. 
MetaboliteXref and SpeciesXref attributes: 
 Ref_type: abbreviation of reference type. The references can be from several 
sources, as citation, E.C number, database, etc. In these entities, all references 
are the database type; 
 Tag: identify the origin of the reference (e.g. KEGG, ChEBI, HMDB, etc.); 
 Value: unique identifier of the reference. 
Reaction-only attributes: 
 Orientation: defines the reaction's reversibility and direction. It can be from left 
to right or reversible; 
 Subsystem: a pathway, where the reaction is included;   
 Type: Identifies the type of reaction. It may be an internal, translocation, drain 
or biomass reaction. 
ReactionLeft/ReactionRight-only attributes: 
 Value:  stoichiometric coefficient.   
The distribution of these attributes by entity is illustrated in Figures 4.2 and 4.3, where 
the Entity-Relationship model is depicted. The tables (entities) are related with one 
another. Each metabolite has several species (since they represent the same 
compound), so these have a one-to-many relationship, acquiring each species the 
primary key (ID) of the corresponding metabolite. The remaining relationships are all 
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like that since a metabolite can have multiple references (metaboliteXref) and 
compartments just like each species can have multiple references. 
Using the local database, it was possible to make several qualitative and quantitative 
data analyses.  In addition, this database is an asset, since in this way there is not always 
the need to load the models' files, decreasing the time of data accesses. 
 
 
 
ID 
Entry 
Name 
Formula 
Charge 
SpeciesXref 
Contains 
Compartment 
Has 
1 N 
Metabolite Species 
1 
N 
Contains 
MetaboliteXref 
Has 
1 
N 
1 
N 
ID 
Entry 
Name 
ID 
ID 
Entry 
Entry 
Name 
Name 
InChI 
Source 
MCLASS 
Tag 
Value 
Ref_Type 
Entry 
Name 
Tag 
Value 
Ref_Type 
ID 
Figure 4.2 - Metabolite’s Entity-Relationship Model. 
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4.3.2 Data Loading from SBML  
Both Recon 2 and HMR 2.0 are available in the SBML format. The core libraries of the 
OptFlux metabolic engineering platform [63] were used to import the models. This can 
be done by using the biocomponents and utilities package, which provide a JSBMLReader 
that uses the JSBML Java library to read and build a Container object with the 
components found in SBML file. However, the SBML format can be quite complex due 
to XML namespace extensions, such as by adding RDF terms to annotate entities. The 
Optflux reader ignores the RDF extension since it is irrelevant for mathematical 
modelling purposes. Therefore, it was necessary to apply some modifications to the 
original JSBMLReader since it did not meet the requirements for this project. These 
modifications included the adaptation to the present Gene-Protein-Rules in the human 
models. 
Initially, the data of both models were processed aiming to adapt to the new common 
data warehouse correcting simultaneously some typing errors. This adaptation includes 
the selection of the useful and relevant data (such as the InChI property or the HMDB 
reference) for this work. 
The models' data were imported, processed and exported to the database described in 
the previous section. This way it was possible to make a deeper and specific models' 
Figure 4.3 - Reaction’s Entity-Relationship Model. 
1 N 
1 N 
Reaction 
ReactionLeft Has 
Has ReactionRight 
ID Entry 
Name 
Source 
Orientation 
SubSystem ID 
Species_id 
Species_entry 
Value 
Species_entry Species_id 
ID Value 
Type 
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analysis also allowing for an easier error detection. The errors found both within models 
in general or specific to an entity were rectified during the processing stage.  
This processing is done in the JSBMLReader class, where the data from the file are 
filtered and rectified so that the extracted information is already prepared to be 
integrated in other platforms. In the case of InChI, for instance, there were several 
problems, such as lacking of the prefix “InChI =” before the code, the fact that the code 
is not within predefined standards by IUPAC, among others. Hence, it is guaranteed that 
only the correctly formatted InChIs are exported, the same happens with other 
properties. After extracting the file data, this information was placed in their respective 
entities (described in the previous section): Metabolite, Compartment, MetaboliteXref, 
Species, SpecieXref, Reaction, ReactionLeft and ReactionRight. 
It was necessary the development of the MetaboliteImpl and ReactionImpl classes that 
get the present information from in the local database.   In the MetaboliteImpl class, the 
relevant information is extracted from the Container and allocated in the first five 
entities mentioned above. Here, for each species a new element of each of these entities 
is created, except when one of these elements already exists. A new metabolite can be 
present in several compartments, and so it can be represented by several species. In this 
way, only one metabolite is created for several species.  
The ReactionImpl class does the same as the previous, although adapted to the 
reactions. For each reaction, a new member of the entity is generated with the same 
name and also of the ReactionLeft and ReactionRight entities. The species usually named 
reactants are represented by ReactionLeft and the products by ReactionRight. 
All these entities are tables that were implemented with the javax.persistence package. 
Posteriorly, with an open session (configured with the properties of the local database) 
the entities and its elements were written (in SQL language) in a beforehand created 
schema. 
The data in the local database can be accessed by using the SQL language in MySQL 
Workbench or combining SQL with Java. The visualization of data in MySQL Workbench 
facilitates the manual detection of typing errors that were not expected.  On the other 
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hand, SQL combined with Java allows all kind of data analysis and also its use for other 
tasks. Making use of the HbmMetaboliteDaoImpl class it is possible to do database 
queries and extract the desired information. In each method, a SQLQuery is created and 
executed through an open session for the database. 
4.4 Integrating Human Models in the Graph 
Database 
4.4.1 Integrating Metabolites 
As stated previously, it is predictable that Recon 2 and HMR2.0 have multiple common 
entities. The most reliable method to compare metabolites is to see if they share the 
same references. This way, strategies were tested taking that assumption into account, 
one using the local database and the other, the unified resource described in the 
previous chapter. 
The initial strategy, through the local database, verifies for each model’s metabolite if it 
possesses external references (to databases). If this occurs, the references are used to 
search in the local database for metabolites with those references. Therefore, for each 
metabolite’s reference a query is made particularly to the MetaboliteXref entity, where 
tag (reference’s type) and value (ID of the reference) have to match simultaneously. In 
case a metabolite from another model with at least an equal reference, is found (tag 
and value) this is considered a pair. However, first it is verified if the previous method 
did not find more than one metabolite (from the other model), since sometimes there 
can be different metabolites with the same reference. Besides, a metabolite with two 
types of references (e.g. KEGG and ChEBI) can have two compatible metabolites in the 
other model, since there can be a metabolite with the reference of the KEGG type and 
the other with the ChEBI type. 
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In another strategy, the Recon 2 and HMR2.0 models were loaded into the unified 
database, making available the species, reactions and compartments of each model. 
Each reference of a new species (in the unified database) is integrated and grouped to a 
cluster, if there is at least another equivalent reference. Since the references are 
associated to their species, if a reference is grouped to a cluster, the species that have 
that reference will stay associated to the respective Cluster (Example in Figure 4.4). This 
way all the equal species are associated to the same cluster, so each cluster represents 
an integrated metabolite. 
 
The fact that the integrated database contains the data of the most important 
databases, and combines them to form clusters, adds credibility and confidence in the 
integration of the metabolites. In order to benefit from this tool, it was necessary that 
the references would be added to each species. The GenerateSpeciesMapping receives 
as input a list of species entries of a model, and for each entry it gets its Species entity, 
through a query to the local database. Through the species, the references associated 
with it are retrieved. These results are put in a map, in which the specie’s entry is the 
key and the value is another map, wherein the key is the reference’s tag and the value 
is the unique identifier of the reference (example in Figure 4.5).  
 
C00001 15377 
h2o 
cpd00001 
 . . .  
Integrated Cluster id = 199713 
M_h2o_m M_02040m 
Figure 4.4 - Example of an integrated cluster. In the square label, are represented two 
species of water, through the entry used in the HMR2.0 and Recon 2 models, 
respectively. The references in the circle (cluster) are from the BiGG, ChEBI, KEGG and 
MetaCyc databases. 
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The references' types that are not present in a given species, are equally placed on the 
map, with an empty string as value. This is important to follow the formation rules of 
the unified database.  This SpeciesMapping is converted into a text file, where the 
MetaboliteSpecies label followed by the labels of the references constitute the header 
and each line has the information in the map corresponding to the header. Thus, this 
file follows the constitution and nomenclature required, so that the upload in the unified 
database can be successful. The upload is done in the Upload class that uses the retrofit 
package. In order to upload the file, a connection to the unified database is prepared 
with RestAdapter.Builder(). The method created uses this connection for 
uploading, having as parameters the file and the model name, and is annotated with the 
POST HTTP verb. All these methods make it possible to populate the species (in the 
unified database) with its references present in the model.  
In the ClusterResults class various methods were built, where the ultimate goal is the 
discovery of the clusterID’s (Integrated Cluster ID for each distinct cluster in the unified 
database) in common (between the two models) and consequently the common 
metabolites. In order to fulfil this objective, several tasks are performed individually, for 
each model, to get a list of the clusterID's present in each. This is shown as Algorithm 2. 
 
 
 
M_h2o_m 
ChEBI 
HMDB 
LG 
LC 
LIPID 
LD 
15377 
HMBD02111 
{} 
{} 
{} 
{} 
Figure 4.5 - Representative schema of an element in SpeciesMapping. LIPID-LIPIDMAPS; 
LC-LigandCompound; LG-LigandGlycan; LD-LigandDrug. 
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In the algorithm SpecieClusterMapping, starting from a set of species entities of a model, 
you gets for each species, the cluster's id to which it is associated, and the references 
responsible for that combination. 
The resulting algorithm map is useful to understand if all references of a species are 
grouped in the same cluster. Sometimes, for some reason (such as a bad annotation of 
the species) the references of the same species are grouped into different clusters. In 
addition, there may be references that do not belong to any cluster. 
If all references (of a species) are integrated within the same cluster, the id of this cluster 
is associated to the speciesEntry. This conclusion is stored in the map named 
SpecieEntry_ClusterID, in which the key is the species’s entry and the value is the 
cluster’s id (Map<speciesEntry, clusterID>). These data are also stored in a text 
file, where the first and second columns are the map’s key and value, respectively, as 
mentioned above. 
Algorithm 2: SpeciesClusterMapping 
 
 
1:  
2:  
3:  
4:  
5:  
6:  
7:  
8:  
9:  
10:  
11:  
12:  
13:  
14:  
15:  
16:  
17:  
18:  
 𝐈𝐧𝐩𝐮𝐭: 𝑆 a set of species entities.  
𝐎𝐮𝐭𝐩𝐮𝐭: 𝑀 −  SpeciesClusterMapping  
𝐏𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐞 ClusterMapping(𝑆)  
𝐟𝐨𝐫 𝑠 ∈  𝑆 𝐝𝐨  
       𝑀[𝑚] ← {}                                             ⇒  Initialize empty dictionary 
       𝑅 ←  𝑠. 𝑔𝑒𝑡𝐼𝑑𝑠𝐶𝑟𝑜𝑠𝑠𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒𝑠() 
       𝐢𝐟 𝑅 ≠  ∅ 𝐭𝐡𝐞𝐧 
            𝑃[𝑝] = {}                                          ⇒  Initialize empty dictionary 
            𝐟𝐨𝐫 𝑟 ∈  𝑅 𝐝𝐨 
                   𝐼 ←  𝑓𝑖𝑛𝑑𝐵𝑦𝑅𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒𝐼𝑑(𝑟) 
                   𝐶 ←  𝑔𝑒𝑡𝐼𝑑𝐶𝑙𝑢𝑠𝑡𝑒𝑟(𝐼) 
                   𝐢𝐟 𝐶 ≠  ∅ 𝐭𝐡𝐞𝐧 
                       𝑝 ← 𝐶 
                       Add 𝐼 to 𝑃[𝑝] 
                   𝐞𝐧𝐝 𝐢𝐟 
            𝐞𝐧𝐝 𝐟𝐨𝐫 
       𝐞𝐧𝐝 𝐢𝐟 
       Add 𝑃 to 𝑀[𝑠] 
𝐞𝐧𝐝 𝐟𝐨𝐫  
𝐫𝐞𝐭𝐮𝐫𝐧 𝑀  
𝐞𝐧𝐝 𝐩𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐞  
Chapter 4: Building a Human Metabolic Integrated Repository 45 
 
 
 
 
Upon completion of these tasks for each model, the list of unique clusterID’s is taken 
from the SpeciesEntry_ClusterID map through of each speciesEntry. The shared 
clusterID’s between the lists represent the common metabolites in the models. For 
every shared clusterID the speciesEntry with which it is associated (on the 
SpecieEntry_ClusterID map) is used, to get the metabolite of this species through the 
local database. Thus, it is possible to find the metabolites integrated between models.  
The species without references will not have a clusterID associated. Therefore, it would 
be useful to populate these species with the respective existing references in the 
metabolic databases. This strategy can also amplify the odds of the species with a 
reference being associated to a cluster, since sometimes that same reference is not 
present in any existing cluster. 
As already mentioned above, each species is composed by a set of data that besides 
describing it, helps in the identification process. Thus, some of these data were selected 
to be used in the pursuit of the lacking references. This search for more references 
through species’ properties is made using the unified graph database in the Neo4j 
platform. In the FindXrefs class, the connection to the unified Neo4j graph database is 
done using the packages and methods made available online by the Neo4j platform. In 
this class, a specific node of a property is found by label, property’s label and property’s 
value.  
This search is made by the execution of a Neo4j query. The query has the following 
example format:  
MATCH (n: InChI) WHERE n.key= 'InChI=1S/Se/q-2' RETURN n 
In this example, “InChI” is the label, “key” is the property’s label, and “InChI=1S/Se/q-2” 
is the property’s value. These variables differ depending on the property of the species 
that is being used. Each property has its specifications both in the unified database and 
in the model. Once the wanted node is found, its relationships, which have the desired 
label, are obtained. The relationship's label also varies depending on the property. 
Following the previous example, in this case the label is: “has_inchi”, because this is the 
relationship's name of the references' nodes with the InChI's nodes. Consequently, it 
can find the nodes that are on the other side of the relationship. These nodes are only 
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really important if they are references, so they are just saved if the label coincides with 
one of the labels of the references (for example: LigandCompound, ChEBI, etc.). 
Given that many species have no unambiguous properties, it is necessary to combine 
two properties reducing the likelihood of ambiguous references to be found. In this case, 
the nodes of interest are those that relate, at the same time, with the nodes of 
properties, and the ones which possess as label one of the ones in the references. The 
query has the following format:  
MATCH (m:MolecularFormula)-[:has_molecular_formula]-(l:%s)-[has_name]-(n:Name)  
WHERE m.key= {MolecularFormula} AND n.key={Name} RETURN l 
In this example, “%s” can be any label reference. The “l” is already the reference node. 
The information in selected nodes, i.e., the references, is placed on a map, with the same 
format of the SpeciesMapping, mentioned above, and it is also converted into a text file. 
Once again, the created file is uploaded in the unified database, updating the species’ 
references.   
All validated pairs of metabolites, were stored in an entity (the repository) created for 
that purpose. 
4.4.2 Integrating Reactions 
The reactions are more complex entities, since they are constituted by species and their 
stoichiometric values, thus the comparison between these becomes harder and requires 
more steps. These steps were implemented in several methods in the 
MatchingReactions class. Each reaction of a model is compared with all reactions of the 
other model, to find their correspondent. This comparison is actually a comparison 
between species, present in a reaction, since those are the ones that will dictate 
whether this reaction is compatible with another, from the other model, or not. 
Hereupon, the resulting map from the metabolite integration is crucial for developing a 
map that consists in a double key and value. The double key represents a 
clusterID-stoichiometric value pair that is exclusive for each species. Therefore, for each 
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species, a map is created, if there is a clusterID. The clusterID is simply taken from the 
SpecieEntry_ClusterID map.  
 The stoichiometric value demands a bigger complexity, since it can differ from one 
reaction to another. In order to get to know the stoichiometric values of each species 
and also the reactions in which it participates, the local database is queried. If the 
species has many stoichiometric values, the map is filled with multiple double keys of 
the same species (example: 215155=-1, 215155=-3, 215155=1). Each double key is 
associated to a list with the reactions that contain the pair represented in it (Figure 4.6). 
This process is shown as Algorithm 3. 
  
 
 
 
 
 
In case a species is a reactant (left side of the reaction), its stoichiometric value is 
multiplied by -1. Consequently, all the reactant species will have a negative 
stoichiometric value enabling its distinction from the products (right side of reaction). If 
a species is a reactant and product in different reactions at the same time, it is 
represented with different double keys, with the same clusterID’s, but different 
stoichiometric values (negative or positive). The information concerning the side of the 
reaction in which a species is will also be retrieved from the local database through the 
ReactionLeft and ReactionRight entities.  
 
 
215155=-1.0 
R_G6PDH2r 
R_G6Pter 
R_HMR_7748 
R_HMR_7749 
R_MI1PS 
R_PGI 
R_r2473 
… 
Figure 4.6 – Example of an element of the SpeciesInReactions map. In the left side is 
double key (clusterID and stoichiometric value) and in right side are the values 
(reactionsEntry). 
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For each reactionEntry (of each model) present in the local database, it can be checked 
to which double key it is associated to in the SpeciesInReactions map. This enables the 
construction of another map, for each model, with the composition of each reaction. In 
other words, to each reactionEntry, is associated a list of clusterID-Stoichiometric Value 
pairs, creating a map ReactionComposition 
(Map<reactionEntry, List<Map<clusterID=stoichiometricValue>>). It is 
possible that not all species, within a certain reaction, have an associated clusterID, so 
it is checked if the list of the reaction's composition has the same size of the same 
reaction in the local database.  
At the end of this method, the results are two ReactionComposition maps, one for Recon 
2 and one for HMR2.0 (example in Figure 4.7). These two maps enable an efficient and 
effective comparison between reactions. 
 
 
Algorithm 3: SpeciesInReactions 
 
 
1:  
2:  
3:  
4:  
5:  
6:  
7:  
8:  
9:  
10:  
11:  
12:  
13:  
14:  
15:  
16:  
 𝐈𝐧𝐩𝐮𝐭: 𝑆 −  𝑆𝑝𝑒𝑐𝑖𝑒𝑠𝐸𝑛𝑡𝑟𝑦_𝑐𝑙𝑢𝑠𝑡𝑒𝑟𝐼𝑑 map  
𝐎𝐮𝐭𝐩𝐮𝐭: 𝑅 −  𝑆𝑝𝑒𝑐𝑖𝑒𝑠𝐼𝑛𝑅𝑒𝑎𝑐𝑡𝑖𝑜𝑛𝑠 map  
𝐏𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐞 𝑆𝑝𝑒𝑐𝑖𝑒𝑠𝐼𝑛𝑅𝑒𝑎𝑐𝑡𝑖𝑜𝑛𝑠(𝑆)  
𝐟𝐨𝐫 𝑠 ∈  𝑆 𝐝𝐨  
       𝑅[𝑟] ← {}                                            ⇒  Initialize empty dictionary 
       𝐶 ←  𝑆[𝑠]    
       𝐢𝐟 𝐶 ≠  ∅ 𝐭𝐡𝐞𝐧 
            𝐟𝐨𝐫 𝑠𝑖𝑑𝑒 ∈  𝑠𝑖𝑑𝑒𝑠 𝐝𝐨 
                    𝐸 ←  𝑔𝑒𝑡𝑅𝑒𝑎𝑐𝑡𝑖𝑜𝑛𝐸𝑛𝑡𝑟𝑖𝑒𝑠(𝑠, 𝑠𝑖𝑑𝑒) 
                    𝐟𝐨𝐫 𝑒 ∈  𝐸 𝐝𝐨 
                            𝑉 ←  𝑔𝑒𝑡𝑆𝑡𝑜𝑖(𝑒, 𝑠𝑖𝑑𝑒, 𝑠) 
                            𝑟[𝐶] ← 𝑉 
                           Add e to 𝑅[𝑟]  
                   𝐞𝐧𝐝 𝐟𝐨𝐫 
            𝐞𝐧𝐝 𝐟𝐨𝐫 
         𝐞𝐧𝐝 𝐢𝐟 
𝐞𝐧𝐝 𝐟𝐨𝐫  
𝐫𝐞𝐭𝐮𝐫𝐧 𝑅  
𝐞𝐧𝐝 𝐩𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐞  
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R_PGI→ {215155=-1.0} {218178=1.0} 
R_HMR_7749→ {215155=-1.0} {218178=1.0} 
R_NH4tn→ {213462=-1.0} {213462=1.0} 
R_HMR_4873→ {213462=-1.0} {213462=1.0} 
 
During the comparison process, the various matching possibilities between the 
reactions are tested. 
First, it is checked if the reactions are a perfect match. The perfect match is achieved if 
the reactants species of a reaction are equivalent to those of the other reaction, and the 
same happens for the products, being mandatory that the reactions have the same 
number of reactants and products. Taking into account that in the ReactionComposition 
map, the reactants and products are identified, respectively, with a negative and 
positive stoichiometric value, it suffices to verify if two composition lists, of different 
reactions, are the same to guarantee the premise mentioned above.  
All reactions, for which the perfect match was not found, go through to the second test. 
This test is the reversible perfect match that consists in the previous strategy with some 
differences at the level of the stoichiometric value. Here, being the reactions reversible, 
they might be in different compliances. As an example, the reactants of the reaction 2 
and the products of the reaction 3 can have the same elements, as well as the products 
of reaction 2 and reactants of reaction 3 (as shown in Figure 4.8). 
 
 
 
Figure 4.7 - Four examples of the reactions’ composition in reactionComposition map. 
The first two (of different models) are the same reaction, the same happens with the 
rest.  
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Aiming to detect the occurrence of these cases, one of the ReactionComposition maps 
of the models to be compared is inverted, meaning that all the stoichiometric values are 
multiplied by -1. The intention behind this step is to invert the composition of the 
reaction, so the reactants (with negative stoichiometric values) became products (with 
positive stoichiometric values) and vice-versa. This way, it is possible to make the 
comparison of the reactions through the same method used in the perfect match (equals 
method), but using an original ReactionComposition map of a model and an inverted 
one of another model (example in Figure 4.9).   
 
The remaining reactions, which until this step do not have a pair, might actually, not be 
identical with any of the other model or may have slight differences, which makes 
difficult the formation of a pair. It is quite common to find identical reactions with 
different balancing equations, concretely in human GSMMs. A thorough study of these 
allows for the realization that there are identical reactions in different models, wherein 
Figure 4.8 - Explanation of the compatibility of reactions. The A, B, C and D letters 
represent the species. The reactants and the products are, respectively, the left side and 
right side of each reaction. 
Inversion 
 R_PGI=[{218178=1.0},{215155=-1.0}] R_HMR_4381=[{218178=-1.0},{215155=1.0}] 
 R_PGI=[{218178=-1.0},{215155=1.0}] 
Figure 4.9 - Representative scheme of how the inversion of the composition of a reaction 
occurs and how it becomes equivalent to another from some other model. The 
reactionEntry R_PGI and the R_HMR_4381 belong, respectively, to the 
ReactionComposition map of Recon 2 and the HMR2.0. 
A B C D Reaction1 
A B C D Reaction2 
C D A B Reaction3 
Match  
Reversible 
Match 
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one is represented by their basic formula and the other has a proton added to the same 
formula. In order to fill these gaps, these reactions are subjected to a last test, the partial 
match.  
In this test, it is accepted that there is one difference between the reactions. First, it is 
verified the case where the difference between reactions is a species that represents a 
proton (1H+). This compound is represented in the Recon 2 and HMR2.0, respectively, as 
M_h_% and M_m02039% (the % symbol represents any letter that represents the 
compartment). These species are associated to a clusterID with the number “218651”. 
This way, it is easy to identify it, so it can be removed from the composition list of each 
reaction (that did not make it in the previous tests). After carrying out this task, these 
reactions are subjected again to the perfect match and reversible perfect match tests. 
Thereby, partially identical reactions are obtained where the difference is a proton. 
The reactions that continue without a correspondence are exposed to one last test, in 
which the original composition lists are used again (without the proton being removed). 
In this case, the elements of each composition list of a reaction are compared one by 
one with the ones from another reaction. If just one element differs between the 
reactions, they are partially identical. 
All the reactions that match in these tests are stored in distinct files, whose title 
identifies the match type, the header the models’ name, and in each line there is a pair. 
The remaining are still unmatched. 
Some reactions in the unified database have references for the KEGG database through 
the integration of their species. Thus, it is also possible to say that two reactions are 
equivalent, if these have the same reference in KEGG. 
All validated pairs of reactions, were stored in an entity (the repository) created for that 
purpose. 
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5 Chapter 5 
Chapter 5  
Results 
In this section, the results of a detailed models' study are revealed. Aiming to proceed 
with the Recon 2 and HMR2.0 models' integration, it was fundamental to know their 
constitution. This enabled the perception of which were the, similarities and differences 
between models, once that, to find equalities, it is also needed a knowledge of the 
differences. 
5.1 Characterizing the human models  
5.1.1 Global characterization of the models 
Primarily, a quantitative analysis of both models' data was done to enable a real 
awareness of the useful information that could be used to intersect both models and 
find similarities. The references to the external databases, as already mentioned 
throughout this work, are the most valuable and useful data that can be used for the 
integration. Hence, the priority was to know the extension of this property in each 
model. Both models have slightly more than half of the annotated metabolites with 
references (Figure 5.1). That is a value that falls short of the expectable and needed for 
a good integration.  
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Each model has references for several types of databases, so it is pivotal to know which 
are the ones present in each model and which are the ones in common. 
In the Recon 2 model, 61% of the species possess references of which 80%, 79% and 
22% have, respectively, references of the ChEBI, HMDB, and KEGG (Compound) types 
(Figure 5.2). Once the sum of these percentages is not 100%, this shows that each 
species has more than one type of reference. Consequently, this situation was verified 
and analysed, being displayed in Figure 5.3 that for more than half of the species that 
own references, those are from the ChEBI and HMDB types.  
W/ References
55%
W/o References
45%
Recon 2
W/ References
59%
W/o References
41%
HMR2.0
Figure 5.1 - Evaluation of the amount of metabolites that have references per model. 
ChEBI
78%
KEGG 
(Compound)
27%
HMDB
73%
Type of references - Recon 2
Figure 5.2 - In the Recon 2 model, 55% of the metabolites have references, and these are 
splitted in three types. 
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Knowing that Recon 2 has more than one type of reference for each metabolite, this is 
very advantageous, since in addition to raising the odds of finding identical metabolites, 
it also increases the trust rating, if a metabolite with more than one type of reference of 
equal value, is found. 
On the other hand, in the HMR2.0 model, it is possible to assume that each metabolite 
only owns one type of reference (Figure 5.4). Also, in this model, the type of ChEBI 
references is prevalent (74% of the metabolites with references).  
Ligand 
Compound
HMDBChEBI
7% 
19% 10% 
14% 
2% 5% 
43% 
Figure 5.3 - In Recon 2, each species can have more than one type of reference. In this 
Venn diagram it can be seen the amount of metabolites that are dependent of just one 
type of reference and also the ones that possess multiple references. 
ChEBI
64%
KEGG (Compound)
23%
KEGG (Glycan)
4%
LipidMAPS
9%
Type of references - HMR2.0
Figure 5.4 - In the HMR2.0 model, 59% of the metabolites have references, and these 
are splitted in four types. 
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Despite the fact that more than half the metabolites of both models have references, 
not all of them are useful to make a direct metabolites comparison. Only the ChEBI and 
LigandCompound are (common) to both models. Focusing in the metabolites with 
references, in Recon 2 85% of these have ChEBI and/or LigandCompound references, 
and in HMR2.0 87% have ChEBI or LigandCompound (since in this model each metabolite 
only has one reference, maximum) meaning that 46% and 51% of the metabolites 
respectively, can be compared using these references only.  
As mentioned in the integration method of metabolites using the unified database, it is 
important to populate all the species with references, so that these can be associated 
to clusters. Taking into account that only 55% and 59% of the metabolites of the Recon 
2 and HMR2.0 models respectively, have references, it is important to know the content 
present in metabolites (and consequently in species) (Table 5.1), in each model, so that 
it can be used in the search for more and new references. 
Table 5.1 - Global analysis of the model’s metabolites. The bottom part of the table bases 
itself only in the metabolites that do not have references (45% and 41%, in Recon 2 and 
HMR2.0, respectively). 
 
The selection of properties (to be used in integrating metabolites using the unified 
database) was made based on quality and quantity of data meaning that the most 
unambiguous and present in most metabolites data, were ideal to identify the 
references of each species accurately and effectively. The selection was also different 
according to the model, since although both have the same basic constitution, they 
differ in some details. 
Number of metabolites w/ Recon 2 HMR 2.0 
Formula  2518 96% 3067 97% 
InChI  1330 51% 0 0% 
References 1434 55% 1863 59% 
W
/o
 
re
fe
re
n
ce
s Formula  1132 95% 1257 97% 
InChI 184 15% 0 0% 
Nothing 60 5% 41 3% 
Chapter 5: Results   56 
 
 
 
 
As it can be seen in Table 5.1, almost all the metabolites of both models have a formula, 
while in InChI, besides only being found in Recon 2, it is only present in 51% of the 
metabolites. Although the InChI property is not so present in the Recon 2 as the formula, 
it is a more valuable data, since it is the most unambiguous and non-redundant. This is 
the ideal characteristic to find new references in a reliable manner. Another property 
that can also be used (that is always present), though it is one of the most ambiguous, 
is the name. In the HMR2.0 case, where the only properties available to be used are very 
ambiguous (Name and Formula), these should be used in simultaneously. 
Apart from this type of properties, references to the least common databases can be 
used to find references to databases such as KEGG and ChEBI. The HMDB reference is 
really important since 10% of the metabolites have it alone and more than half have it 
along with other references. The BiGG and SEED databases can be withdrawn from the 
species’ entry, removing the prefix "M_" and the suffix "_%", wherein "%", may be any 
letter that identifies the compartment. This becomes very useful since all the Recon 1 
species have references for these databases. Being the Recon 2 its evolution one can 
only wait that lots of its species are within these databases.  
In the HMR2.0, there is only a single characteristic that can be used alone besides the 
main references (ChEBI and KEGG). The reference LIPIDMAPS is exclusive in 9% of the 
metabolites.  
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In both models, there are four types of reactions: the Internal, Translocation, Drain and 
Biomass. These have about the same distribution in both models (Figure 5.5).  
 
Figure 5.5 - Type of reactions in Recon 2 and HMR2.0 models. 
 
The Internal type contains reactions in which the reactants and the products are in the 
same compartment. The translocation type represents the reactions that transport a 
compound of a compartment to the other. The drain reactions are metabolite uptake or 
excretion fluxes reactions. In Recon 2, these are characterized by having only a 
compound in its constitution. In turn, the HMR2.0 model uses the boundary 
compartment, to complete its reactions, so there is no reaction with one of the sides 
empty. These reactions belong to the Exchange subsystem, in both models. The biomass 
reactions are generic, where a big quantity of reactants results in one or a small number 
of products. 
5.1.2 Examples of inconsistencies found  
In the Recon 2 GSMM, 103 metabolites were found with more than a name associated, 
meaning that each of these metabolites had its origin in species that have the same 
compound, but have different names. The average rate of different names per 
metabolite is two. Despite not being erroneous since there are always synonyms, the 
difference between names is an inconsistency that can lead to integration errors. Since 
the use of different names for the same compound is one of the major obstacles to the 
Drain
9%
Internal
56%
Biomass
0%
Translocation
35%
Type of Reactions - Recon 2
Drain
6%
Internal
60%
Biomass
0%
Translocation
34%
Type of Reactions - HMR2.0
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comparison between multiple models, it would be important to avoid situations like 
these within the actual model.  
As shown in the Tables 5.2 and 5.3, cases were detected where for the same metabolite 
there were species with different references. In those examples, it can be seen that 
there is also the problem of different names for the same metabolite. Also, not all 
species are as complete as they could be, since some of its peers contain more 
references.  
Table 5.2 - Representative table of an inconsistency situation. Specifically in the Name, 
ChEBI and Ligand Compound (LC) entities. Met_id-Metabolite_id. 
 
Table 5.3 - Representative table of an inconsistency situation. Specifically in the Name, 
ChEBI and Ligand Compound (LC) entities. Met_id-Metabolite_id. 
ID Entry Name Charge Formula ChEBI HMDB LC Met_id 
847 M_atp_x ATP(4-) -4 C10H12N5O13P3 57299 538 C00002 444 
848 M_atp_c ATP(4-) -4 C10H12N5O13P3 30616 538 C00002 444 
849 M_atp_m ATP(4-) -4 C10H12N5O13P3 57299 538 C00002 444 
850 M_atp_l ATP(3-) -4 C10H12N5O13P3 57299 538 NULL 444 
851 M_atp_n ATP(3-) -4 C10H12N5O13P3 57299 538 NULL 444 
852 M_atp_r ATP(4-) -4 C10H12N5O13P3 57299 538 C00002 444 
853 M_atp_e ATP(4-) -4 C10H12N5O13P3 57299 538 C00002 444 
854 M_atp_g ATP(3-) -4 C10H12N5O13P3 57299 538 NULL 444 
 
In Table 5.4, it can be seen that a metabolite from the GSMM HMR2.0 has species with 
different formulas. This difference is not substantial, but like in the previous cases, it can 
cause integration problems. Other than that, a search for the available reference (Ligand 
Compound) has revealed that none of the formulas are correct, since the formula 
ID Entry Name Charge Formula ChEBI HMDB LC Met_id 
2079 M_adp_g ADP(3-) -3 C10H12N5O10P2 456216 1341 NULL 1090 
2080 M_adp_e ADP(3-) -3 C10H12N5O10P2 456216 1341 NULL 1090 
2081 M_adp_n ADP(3-) -3 C10H12N5O10P2 456216 1341 NULL 1090 
2082 M_adp_l ADP(3-) -3 C10H12N5O10P2 456216 1341 NULL 1090 
2083 M_adp_m ADP -3 C10H12N5O10P2 456216 1341 C00008 1090 
2084 M_adp_r ADP(3-) -3 C10H12N5O10P2 456216 1341 NULL 1090 
2085 M_adp_x ADP(3-) -3 C10H12N5O10P2 456216 1341 NULL 1090 
2086 M_adp_c ADP -3 C10H12N5O10P2 16761 1341 C00008 1090 
Chapter 5: Results   59 
 
 
 
 
associated to this compound is C12H17O10.Na (Sodium 2-O-L-rhamnopyranosyl-4-
deoxy-alpha-L-threo-hex-4-eno-pyranosiduronate).  
 
Table 5.4 - Representative table of an inconsistency situation. Specifically in the Formula 
entity. LC-LigandCompound 
5.2 Integration results  
5.2.1 Metabolites 
Through the metabolites integration method that uses the local database (described in 
section 4.4.1), a list of the metabolite pairs was created. This list was based in the use of 
these references, where it was demanded that there was at least one shared reference 
among the compared metabolites. It was not possible to demand that all the references 
of a Recon metabolite were similar to those of another HMR2.0 metabolite, since, as 
already mentioned, each HMR2.0 metabolite only has one type of reference. At the end 
of this method, 550 pairs of metabolites were obtained, in which each metabolite is 
unique. 
In the initial list of metabolite pairs, 32 cases were found in which every distinct Recon 2 
metabolite was compatible with more than a metabolite from the HMR2.0,  the opposite 
also happened in 19 cases (see example in Figure 5.6).  
 
 
 
 
ID Entry Formula LC Metabolite_id 
10388 M_m02357x C12H17O10 C08241 5427 
10389 M_m02357c C12H17O10. C08241 5427 
10390 M_m02357s C12H17O10. C08241 5427 
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Figure 5.6 - Examples of different metabolites that are compatible with just a metabolite 
of the other model. The first example refers to this occurrence of the HMR2.0 to the 
Recon 2, and the second is the reverse. 
 
After detecting this situation, a specific study of each model was made, to understand 
how many cases of different metabolites with the same references exist, and what 
motivates this. In order to proceed with this task, the same method (metabolites’ 
integration) was used, but with the peculiarity of the input (entry of model 1, entry of 
model 2) being solely from a model, meaning that the model will run “against” itself. 
Besides that, in this case, it is accepted that, for each metabolite, there can be a list of 
compatible metabolites. This way, the different metabolites that possess the same 
references within each model, are found.  
After the conclusion of this task, 62 cases were found in the Recon 2, of two different 
metabolites that share the same references and 1 case with three, making a total of 124 
metabolites. In the HMR2.0, there are 14 cases that are very variable in terms of 
metabolites’ number, which consist in: 1 case with three, nine and eleven; 3 cases of 
eight and 8 cases of two metabolites, totalling 63 metabolites. A manual verification of 
these cases, has allowed to realize that, in both models, these metabolites contain 
references that point to generic compounds or, when they point to a specific compound, 
its similar differs in just a small part of the structure. Additionally, only the name of these 
metabolites, apparently similar, is different, amongst the properties. The name’s 
constitution of these metabolites, indicates the differences at the isomer structure’s 
M_m00241 
M_12dgr120_ 
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level (e.g.: 1,2-diacylglycerol-LD-SM pool; 1,2-diacylglycerol-bile-PC pool). Deep down, 
these metabolites are the same compound but with different isomer structures.  
This raises one more problem in terms of integration, because, even though these 
metabolites seem apparently similar, they participate in different reactions. If it were 
assumed that all the similar ones are the same, there would be a problem in the 
reactions, because lots of distinct reactions within the same model would become the 
same. Thereby, it would be useful if there were different references for each different 
isomer structure of a compound.  
Using the metabolites' integration method that aims for the use of the unified database, 
after its species were populated with the references within the models, 809 clusterID in 
common between models were obtained, meaning 809 shared metabolites. 
In order to increase these results, new references were sought through the Neo4j 
platform, as described in section 4.4.1. The general results of this search were very good 
since several species were populated with references (Table 5.5). In the Recon 2 case, 
the InChI property was the one where there were more populated species (44% of the 
species). Regarding the HMR2.0, as it was expected, once there are properties that are 
present in all the species, the Name & Formula properties were the ones that resulted 
in more populated species (25%). However, it was a far smaller percentage, when 
compared with the Recon 2's best result. Additionally, in the Recon 2's case, it was 
possible to use more properties (to obtain references) and none of them originated a 
result lower than 26%. 
Table 5.5 - Number of species, which through a certain property, have obtained 
references, by search method for references in Neo4j platform of the unified database. 
Recon 2 HMR2.0 
BiGG 1931 38% LIPIDMAPS 145 2,4% 
SEED 1422 28% Name & Formula 1551 26% 
InChI 2204 44%    
HMDB 1321 26%    
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Even though all these data indicate that the Recon 2's species were populated with more 
references, only a detailed analysis can confirm if it was really an advantage. In Figure 
5.7, that analysis is made, where, for each property, the number of populated species 
with references reached is divided into three categories. The first category (brown 
column), exposes the number of species that did not have any references and earned 
some, after being populated. The second category (green column) represents the 
number of species that already had references in the model, but were populated with 
new references. At last, the third category (blue column) exhibits the number of species 
that already had references and were not populated, since the ones earned were 
repeated.  
As the species are populated, it is expected that the number of species associated with 
a cluster increases, since more species have references that may be contained in a 
cluster. Consequently, the number of clusterIDs (representing metabolites) also 
increases, so this was also a parameter analysed for each model. The yellow, green and 
blue lines represent, respectively, the Recon 2 and HMR2.0 models, and the clusterIDs 
in common (i.e. the metabolites). The criterion used to define the order in which the 
species in the unified database were populated was the number of species for which 
each property obtained references. Thus, the species (in the unified database) have 
been populated with references from each property in the following order: InChI, BiGG, 
SEED, HMDB, Name & Formula and LIPIDMAPS. 
Thereafter, the unified graph database was updated with the new references. This way 
there were more species included in clusters, raising the number of generated 
metabolites and consequently the number of metabolites’ pairs between models. 
The number of species that were devoid of references and that earned them, is quite 
low, as opposed to the number of species that have earned new references, that is quite 
high. The number of integrated metabolites increased, every time the species in the 
unified database were populated with the references that came from the respective 
properties, with exception of the SEED property. It is normal that this happened, since 
the BiGG and SEED databases share most of their references. The number of shared 
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metabolites between models also increased, as the species were being populated, 
reaching a peak of 1105. 
 
Figure 5.7 - Gains with the population of the species in unified database. The columns 
represent the number of species that were populated with references through a certain 
property. The lines are the clusterID numbers (metabolites) that were obtained (through 
the unified database), as the species were being populated. 
 
From the list of 1105 metabolite pairs, 526 are in common with the list mentioned above 
(with 550 metabolites’ pairs). This particular situation led to an increase of common 
metabolites that rose from 550 to 1129 (Figure 5.8). 
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In this schema, it is possible to verify that there are metabolites, that despite being 
associated to a cluster, are still not part of the metabolites shared by the models. These 
metabolites are highly likely exclusive to each model, since, if they were identical, they 
would share the same cluster, and that does not happen.  
In Recon 2, 33% of the metabolites were not associated to any cluster, nor shared 
metabolites through their possible references in the model. In the HMR2.0 case, these 
metabolites represent 30% of the total metabolites. The shared metabolites represent 
43% and 36% of the Recon 2 and HMR2.0 metabolites, respectively.  
5.2.2 Reactions 
After the analysis and integration of the metabolites is done, the next step is the 
reactions’ integration. This integration was done using the methods described in section 
4.3.2. The general results are pretty satisfying (Table 5.6). In Recon 2, 44% of reactions 
are integrated. It is also important to note that these integrated reactions represent 71% 
of the reactions’ number in the Recon 2’s ReactionComposition map (62% of the total 
reactions). Concerning the HMR2.0, 43% of the reactions are integrated. Of the reactions 
present in the HMR2.0’s ReactionComposition map (63% of the total reactions), 68% are 
integrated. 
Cluster 
W/o Cluster W/o Cluster 
Cluster 
HMR2.0 
560 
945 
 
110 
861 
1129 
Recon 2 
Figure 5.8 - Representation of numeric values of metabolites found through the Clusters 
of the unified graph database versus the metabolites of the local database (originated 
from the models). In the middle are the shared metabolites. 
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Table 5.6 - Number of unique reactions, by method, for which there is correspondence 
in the other model. The grey columns represent the results using the reversibility. 
 
Perfect Proton Partial 
Total 
Recon 2 2230 268 636 58 53 3 3248 
HMR2.0 2479 263 596 66 67 3 3474 
 
In this integration, using the reactions in general, it was detected that some reactions of 
different types formed a pair. This happens because the same reaction (constitution 
wise), can act in different ways in the human organism. In other words, a reaction can 
either be internal or translocation, since their compounds are the same, changing only, 
the compartments in which they are present. An example of that are the Recon 2 
reactions with the R_GLYC3PFADm( 5.1 ) and R_G3PD2m( 5.2 ) entries.  
 M_glyc3p_m + M_fad_m → M_fad_m + M_dhap_m ( 5.1 ) 
 M_glyc3p_c + M_fad_m → M_fad_m + M_dhap_c ( 5.2 ) 
 
Both reactions are identical to HMR2.0 reaction with the entry R_HMR_0449 (5.3). 
 M_m01802m + M_m02914m → M_m01803m + M_m01690m ( 5.3 ) 
 
Despite these similarities, it is important to compare reactions of the same type, so that 
the integration's quality can be improved. Furthermore, it is possible to have a better 
perception of the differences between models. This way, the integration method was 
again executed using the reactions (of both models) of the same type. The total results 
obtained (Table 5.7) for each model, are different from the first, as there has been an 
increase in the number of unique reactions integrated (about +6.5%) for the Recon 2 
model, and a decrease (about -1.1%) for the HMR2.0 model. 
The justification for this change of values sticks with the fact that there are no longer 
reactions that stay paired with a reaction of a different type. When this is allowed, a 
reaction that is paired is forbidden of pairing with a reaction of its type. This event causes 
some noise that is mostly provoked by the drain-type reactions of the HMR2.0 model. 
These pair unduly, frequently, with Recon 2's translocation reactions.  
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It can be verified that the total number of reactions of each model, is not the same. 
These occurrences are due to the existence of equal reactions that occur in different 
compartments, but that are distinguished by the model. For the most part of the 
reactions, a pair that acts in the same compartment is found, but sometimes that does 
not happen. In these cases, it is accepted that two reactions with equal compositions 
but different compartments, form a pair. If these data were discarded, integration data 
that could be valuable for the formation of a unified model, would be lost. For instance, 
the Recon 2's reaction with the "R_TREH" entry is present in the Cytosol compartment, 
but it is not in that same HMR2.0 compartment (it is in Extracellular). In the future, it 
will be important to know that the "R_TREH" reaction has a compatible reaction (in the 
other model), even though it is in a different compartment.  
It is also important to note that, both results (Tables 5.6 and 5.7) have shown that all the 
integration strategies (Perfect, Partial, etc.) used were useful, being the perfect match 
(as expected), responsible for majority of the results. 
Table 5.7 - Number of unique reactions, by type and method, for which there is 
correspondence in the other model. The Recon2 is the grey column and the HMR2.0 is 
the white. * line with results using the reversibility. 
 
Internal Transport Drain 
Perfect 725 734 1484 1493 0 0 
Perfect * 263 263 0 0 0 0 
Proton 570 538 65 58 0 0 
Proton * 58 66 0 0 0 0 
Partial 0 0 0 0 294 281 
Partial * 1 1 0 0 0 0 
Subtotals 1617 1602 1549 1551 294 281 
 
The results obtained from the integration by reaction type allowed the clarification and 
increase of the method's quality. The reactions of the drain type only corresponded 
through the partial integration method, due to the fact that these, in Recon 2, are only 
constituted by one compound, being that in HMR2.0 they are constituted by two, as 
explained above. This way, even though the integration was partial, the reactions (of 
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both models) that constituted a pair can be considered equal. This means that, in reality, 
there is only a pair of reactions (internal type) that differs in a compound.  
Through this method, 3460 and 3434 reactions of the Recon 2 and HMR2.0, respectively, 
were integrated. This represents 75% and 67% of the reactions in the respective 
ReactionComposition maps. Taking into account, that the majority had a perfect match 
and, in the others, the difference was in a proton only, one can conclude that the rest 
of the reactions in the maps (25% and 33%) really are different. Having as a base that 
62% and 63% of the Recon 2 and HMR2.0's total reactions, respectively, are in the 
respective ReactionComposition maps, meaning that 47% and 42% of the total reactions 
are integrated. Thus, it is likely that 16% of the Recon 2 and 21% of the HMR2.0 reactions 
are exclusive. 
From the integrated reactions, 3253 (1529 Internal, 1444 Translocation and 280 Drain) 
are unique pairs, hence, the reactions of different compartments, are not contemplated 
here.  
5.3 Analysis of a specific subsystem: the 
Glycolysis Pathway   
The study of models by parts, as subsystems, allows for a real perception of the 
differences between the models, seeing that the same subsystem in different models 
can have small differences due to the way the pathway was completed. Besides that, 
there are also different subsystems among models. Seeing that this property also has 
different nomenclatures depending on the models, it is difficult to understand which are 
the common subsystems in both models. The created list of reactions’ pairs through the 
references present in the unified database, allows for a primary perception of which 
subsystems will be common. This list is constituted by the common references (28), the 
respective entries of the reactions' models and subsystems associated to each reaction 
(Table A.1). This list has a total of 86 lines, being that there were various cases where 
the same reaction had multiple different entries due to the discrimination of the 
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compartment in which they act. Individually, in the unified database, the Recon 2 has 51 
reactions with references (of which 33 are unique) and HMR2.0 has 1932 reactions with 
references (of which 1496 are unique).  
Through Table A.1, it is possible to say with great certainty, that some subsystems are 
the same, like the Recon 2’s Tetrahydrobiopterin metabolism and the HMR2.0’s 
Biopterin metabolism. In other cases, the result is inconclusive, and it might be due to 
the fact that there are few examples or due to being ambiguous, e.g. the Recon 2’s 
Sphingolipid metabolism subsystem has reactions that, in the HMR2.0, belong to the 
Sphingolipid metabolism subsystem just as to the Glycosphingolipid metabolism. Seeing 
that, a study of the subsystems in general, would be very laborious and long-lasting, a 
reference pathway was chosen for the effect. 
The Glycolysis is one of the most important and described pathways. This is present in 
nearly all living organisms, since it is a great source of energy, that does not depend on 
oxygen [66]. Succinctly, in this pathway, the glucose is converted into pyruvate, through 
several steps. Considering these factors, there is a high probability of the Glycolysis 
pathway to be similar in both models, and also of being fully integrated.  
So, its existence in the models was confirmed, and the nomenclature used was verified. 
In the Recon 2, this pathway is named “Glycolysis/gluconeogenesis” and in HMR2.0 is 
“Glycolysis / Gluconeogenesis”. The Gluconeogenesis pathway, that is associated to 
Glycolysis, is basically its inverse, i.e. the Gluconeogenesis is production of glucose from 
pyruvate. 
Although the names used are the same, there are small details that prevent using the 
same nomenclature for both models. In other words, for the reactions that are part of 
this pathway in each model, it is necessary to use two different strings. Therefore, the 
list of reactions' names and list of metabolites' names are obtained through of the local 
database by the correspondent subsystem (pathway).  
As expected, the number of reactions, species and metabolites is very similar (Table 5.8). 
In particular, the number of reactions is the same even though that does not mean they 
are exactly the same. 
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Table 5.8 - Numeric results of subsystem Glycolysis. 
 
 
All the species of this subsystem are associated to a cluster, thus it is possible to make a 
complete comparison. Resorting to the methods described in section 4.4.1 (Integrating 
Metabolites) it was possible to find 37 clusters (in the unified database) which are 
equivalent to 37 metabolites shared by models. Individually, the number of clusters for 
the Recon 2 is the same as the metabolites’ number (51) in the local database. In the 
case of the HMR2.0, the number of clusters is 44, so there are least two metabolites, 
compared with data from the local database. The analysis in this particular situation has 
led to the conclusion that what originated this situation are metabolites with a small 
difference in structure (in specific, beta carbon). 
Although both models have 40 reactions, the shared reactions list has a total of 28 
reactions, having each model 12 exclusive reactions, in this subsystem. These 
conclusions were drawn using the methods described in the section 4.4.2 (Integrating 
Reactions), where only the entries of these subsystem’ reactions were given as input. 
The manner in which the models represent the subsystem is illustrated in the schema of 
the Figure 5.9. The construction of this schema was possible due to the results obtained 
through the reactions’ integration as well as the manual verification. The manual data 
analysis allowed the detection of reactions that transformed the same compounds but 
resorting to different co-factors, as it can be verified in the reactions number 2, 2.1 and 
2.2 of the Table 5.9. These reactions cannot be considered equal, because their 
constitution is different, even though the substratum and the product are the same. 
Moreover, cases were solved in which two different reactions of a model were the equal 
to just one from the other model. Again, this is explained by the reactions that occur in 
different compartments. For instance, the “R_ALDD2x” and “R_ALDD2xm” 
reactions (Recon 2). The first occurs in the cytosol compartment and the second in the 
mitochondrion. Both were compatible with the “R_HMR_8357” reaction (HMR2.0) that 
occurs in the mitochondrion compartment. This way, the “R_ALDD2xm” and 
Number of Reactions Species Metabolites 
Recon 2 40 84 51 
HMR2.0 40 71 46 
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“R_HMR_8357” reactions were considered identical and the “R_ALDD2x”, exclusive to 
Recon 2 in this subsystem, not least because, it is identical to the reaction 
“R_HMR_1568”, which in the HMR2.0 case, participates in the Pyruvate subsystem. 
Over the construction  of the Glycolysis pathway schema, comparing with the literature 
[67], reactions were detected (identified in the models as part of the Glycolysis 
subsystem) that belong to another subsystems, but that produce or consume the 
Glycolysis substrate. These reactions are the numbers: 14, 14.1, 15, 24, 30 and 31. The 
subsystems to which they should belong are indicated in the schema. In the case of the 
reactions number 30, 31 of the Pyruvate metabolism, these are two reactions that from 
Acetate produce Acetyl-CoA, having as an intermediate the Acetyl adenylate compound. 
In the Glycolysis the Acetate consumption and the Acetyl-CoA production is the 
responsibility of only one reaction (present on the KEGG database with the ID number 
R00235).  
The fundamental part of this pathway is shared by both models, existing parts that are 
represented exclusively by one of the models. The HMR2.0 model is the most complete 
since it as almost all the reactions that participate in this pathway [67]. Recon 2 focuses 
mostly in the essential reactions of this pathway, having several reactions for each step 
of it.  
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Figure 5.9 - Representation of glycolysis subsystem. The colours dark yellow, blue and green, 
represent, respectively, the unique reactions of Recon 2, HMR2.0, and the reactions shared 
by both. 
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Table 5.9 - Reactions’ data (identified by a number) represented in the schema above. 
The colours dark yellow, blue and green, represent, respectively, the unique reactions 
of Recon 2, HMR2.0, and the reactions shared by both. The cofactors that are 
represented by the same order of its reactions, being “-“ the discerning element of the 
left and right sides. The entry of the reactions are abbreviated, missing the prefix (“R_” 
and “R_HMR_”). Subtitle of the compartments: C-Cytosol, R-Endoplasmic reticulum, M-
Mitochondria, X(Recon 2) -Peroxisome, P(HMR2.0)-Peroxisome.  
Number Recon 2 Cofactors Comp. HMR2.0 Cofactors Comp. 
1 PGMT  C 4396  C 
2 r0354 ITP-IDP C    
2.1 r0355 dATP-dADP C    
2.2 CBPPer Cbp+H+-NH4++CO2 R 8652 Cbp-NH3+CO2 R 
3 G6PPer H2O-Pi R 4521 H2O-Pi R 
4 HEX1 ATP-ADP C 4394 ATP-ADP C 
5    7745  C 
6    7746 ATP-ADP C 
6.1    7747 ADP-AMP C 
7    7749  C 
8    7748  C 
9 PGI  C 4381  C 
10 PFK ATP-ADP C 4379 ATP-ADP C 
10.1    4301 UTP-UDP C 
11 FBP  C 4377  C 
12 FBA  C 4375  C 
13 TPI  C 4391  C 
14 G3PD2m FAD-FADH2 C & M    
14.1 r0202 NAD+-NADH+H+ X    
15    4355  C 
16 GAPD Pi+NAD+-NADH+H+ C 4373 Pi+NAD+-NADH+H+ C 
17 PGK ADP-ATP C 4368 ADP-ATP C 
17.1 ACYP  C 4370  C 
18 DPGM  C 4371  C 
19 DPGase H2O- Pi C 4372 H2O- Pi C 
20 PGM  C 4365  C 
21 ENO -H2O C 4363 -H2O C 
22 PEPCK GTP-GDP+CO2 C    
22.1 PEPCKm GTP-GDP+CO2 M    
23 PYK ADP-ATP C 4358 ADP-ATP C 
23.1 r0165 UDP-UTP C    
23.2 r0280 dADP-dATP C    
23.3 r0153 CDP-CTP C    
23.4 r0413 dGDP-dGTP C    
23.5 r0122 GDP-GTP C    
24    4360 H2O + NADP+ -
NADPH + H+ 
C 
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25 r0173 NAD+-NADH+H+ X 4281 NADH+H+-NAD+ P 
25.1 LDH_L NAD+-NADH+H+ C 4388 NADH+H+-NAD+ C 
26 PDHm CoA +NAD+-NADH 
+ H+  +  CO2 
M 4137 CoA +NAD+-NADH 
+ H+  +  CO2 
M 
27    6410 -CO2  
28    6412 CoA- M 
29 ACS CoA+ ATP - 
AMP+PPi 
C 4097 CoA+ ATP - 
AMP+PPi 
C 
29.1 ACSm CoA+ ATP - 
AMP+PPi 
M 4099 CoA+ ATP - 
AMP+PPi 
M 
30    4108 CoA-AMP C 
31    4133 ATP- PPi C 
32 ALDD2y H2O+NADP+-
NADPH+H 
C 4283 H2O+NADP+-
NADPH+H 
C 
32.1 ALDD2xm H2O+NAD+-
NADH+H 
M 8357 H2O+NAD+-
NADH+H 
M 
32.2 ALDD2x H2O+NAD+-
NADH+H 
C    
33 ALCD2yf NADP+-NADPH+H C 3907 NADP+-NADPH+H C 
33.1 ALCD2if NAD+-NADH+H C 3905 NAD+-NADH+H C 
33.2 ETOHMO O2 + NADPH+H-
NADP+ +  H2O 
C 8757 O2 + NADPH+H-
NADP+ +  H2O 
C 
33.3 CAT2p H2O2-H2O X 8360 H2O2-H2O P 
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Chapter 6  
Conclusions 
The main objective of this work was to build an integrated, unified and global repository 
of the human metabolism. This presupposed the design of a pipeline, to integrate the 
most important entities of the models, which are the metabolites and the reactions. The 
base models used for this integration were the Recon 2 and HMR2.0 GSMMs, since they 
are the most up to date.  
The initial study made to the models revealed the necessity to extend the annotation of 
the species, with additional references from external databases. The usage of a unified 
database revealed to be very advantageous, since it increased the detection rate by 
more than 50%, of the common metabolites between the models. The effective 
integration of the metabolites is essential for the integration of the reactions. 
As result of the integration, a repository was built, that given an entry, it can easily tell 
if there is a corresponding metabolite or reaction in the other model. This is very 
important so that, in the future, a complete and unified model can be created.  
The manual analysis of the Glycolysis subsystem, gave us the conclusion that the 
designed methods of this work, to automatically integrate the metabolites and the 
reactions of the Recon 2 and the HMR2.0 models, gave us a very satisfying initial results. 
To consider the integration perfect is relative, since the essential part is to know, which 
are the metabolites and reactions that the models share. So, to consider two reactions 
identical, where the difference is in the compartment where they act within their model, 
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is not wrong, since they are actually the same. Beyond that, this information can be 
helpful in the future to create a unified model. In the construction of a unified model, it 
is important to know that there is a shared reaction between models, even if it is present 
in different compartments in each model. It is clear that, in the study of the Glycolysis 
subsystem, it was important to clarify these little differences, so that a detailed analysis 
could be performed, that would highlight the difference between models.  
A limitation of this work is the lack of unique identifiers for all the metabolites. This limits 
severely the automatic integration, since it opens space for ambiguity, and it is not 
possible to tell with any certainty, if the non-integrated metabolites and reactions, are 
actually different. Therefore, as a future work, it would be important to manually verify, 
for the remaining metabolites and reactions, their identity and if they are exclusive to 
each model. Strategies to identify the common subsystems could aid in this task. 
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Results 
 
Table A.1 - Integration's result of the model's reactions from Recon 2 and HMR2.0, 
employing the direct comparison method through of the KEGG (Reaction) references 
(common element). 
Recon 2 
 
HMR2.0 
Entry Subsystem KEGG Entry Subsystem 
R_r0013 Aminosugar metabolism R00022 R_HMR_3988 Amino sugar and 
nucleotide sugar 
metabolism 
R_RE3519X Arachidonic acid 
metabolism 
R07036 R_HMR_1058 Arachidonic acid 
metabolism 
R_RE3519X Arachidonic acid 
metabolism 
R07036 R_HMR_1057 Arachidonic acid 
metabolism 
R_RE3519X Arachidonic acid 
metabolism 
R07036 R_HMR_1055 Arachidonic acid 
metabolism 
R_RE3519R Arachidonic acid 
metabolism 
R07036 R_HMR_1058 Arachidonic acid 
metabolism 
R_RE3519R Arachidonic acid 
metabolism 
R07036 R_HMR_1057 Arachidonic acid 
metabolism 
R_RE3519R Arachidonic acid 
metabolism 
R07036 R_HMR_1055 Arachidonic acid 
metabolism 
R_RE3519C Arachidonic acid 
metabolism 
R07036 R_HMR_1058 Arachidonic acid 
metabolism 
R_RE3519C Arachidonic acid 
metabolism 
R07036 R_HMR_1057 Arachidonic acid 
metabolism 
R_RE3519C Arachidonic acid 
metabolism 
R07036 R_HMR_1055 Arachidonic acid 
metabolism 
R_RE3520N Arachidonic acid 
metabolism 
R07039 R_HMR_1043 Arachidonic acid 
metabolism 
Appendix A: Conclusions   77 
 
 
 
 
Recon 2 
 
HMR2.0 
Entry Subsystem KEGG Entry Subsystem 
R_RE3520N Arachidonic acid 
metabolism 
R07039 R_HMR_1045 Arachidonic acid 
metabolism 
R_RE3520N Arachidonic acid 
metabolism 
R07039 R_HMR_1049 Arachidonic acid 
metabolism 
R_RE3520N Arachidonic acid 
metabolism 
R07039 R_HMR_1048 Arachidonic acid 
metabolism 
R_RE3520
M 
Arachidonic acid 
metabolism 
R07039 R_HMR_1043 Arachidonic acid 
metabolism 
R_RE3520
M 
Arachidonic acid 
metabolism 
R07039 R_HMR_1045 Arachidonic acid 
metabolism 
R_RE3520
M 
Arachidonic acid 
metabolism 
R07039 R_HMR_1049 Arachidonic acid 
metabolism 
R_RE3520
M 
Arachidonic acid 
metabolism 
R07039 R_HMR_1048 Arachidonic acid 
metabolism 
R_RE3520E Arachidonic acid 
metabolism 
R07039 R_HMR_1043 Arachidonic acid 
metabolism 
R_RE3520E Arachidonic acid 
metabolism 
R07039 R_HMR_1045 Arachidonic acid 
metabolism 
R_RE3520E Arachidonic acid 
metabolism 
R07039 R_HMR_1049 Arachidonic acid 
metabolism 
R_RE3520E Arachidonic acid 
metabolism 
R07039 R_HMR_1048 Arachidonic acid 
metabolism 
R_RE3520C Arachidonic acid 
metabolism 
R07039 R_HMR_1043 Arachidonic acid 
metabolism 
R_RE3520C Arachidonic acid 
metabolism 
R07039 R_HMR_1045 Arachidonic acid 
metabolism 
R_RE3520C Arachidonic acid 
metabolism 
R07039 R_HMR_1049 Arachidonic acid 
metabolism 
R_RE3520C Arachidonic acid 
metabolism 
R07039 R_HMR_1048 Arachidonic acid 
metabolism 
R_r0744 Bile acid synthesis R04813 R_HMR_1644 Steroid metabolism 
R_r0744 Bile acid synthesis R04813 R_HMR_1642 Bile acid biosynthesis 
R_TXASr Eicosanoid metabolism R02268 R_HMR_1313 prostaglandin 
biosynthesis 
R_RE3556C Eicosanoid metabolism R04565 R_HMR_1401 prostaglandin 
biosynthesis 
R_RE3567C Eicosanoid metabolism R05057 R_HMR_1323 prostaglandin 
biosynthesis 
R_RE3566C Eicosanoid metabolism R05056 R_HMR_1322 prostaglandin 
biosynthesis 
R_r0717 Fatty acid oxidation R04738 R_HMR_3122 Beta oxidation of 
even-chain fatty acids 
(mitochondrial) 
R_r0717 Fatty acid oxidation R04738 R_HMR_3079 Beta oxidation of 
even-chain fatty acids 
(peroxisomal) 
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Recon 2 
 
HMR2.0 
Entry Subsystem KEGG Entry Subsystem 
R_r0729 Fatty acid oxidation R04744 R_HMR_3143 Beta oxidation of 
even-chain fatty acids 
(mitochondrial) 
R_r0729 Fatty acid oxidation R04744 R_HMR_3091 Beta oxidation of 
even-chain fatty acids 
(peroxisomal) 
R_r0734 Fatty acid oxidation R04749 R_HMR_3157 Beta oxidation of 
even-chain fatty acids 
(mitochondrial) 
R_r0734 Fatty acid oxidation R04749 R_HMR_3099 Beta oxidation of 
even-chain fatty acids 
(peroxisomal) 
R_r0731 Fatty acid oxidation R04746 R_HMR_3150 Beta oxidation of 
even-chain fatty acids 
(mitochondrial) 
R_r0731 Fatty acid oxidation R04746 R_HMR_3095 Beta oxidation of 
even-chain fatty acids 
(peroxisomal) 
R_r0720 Fatty acid oxidation R04740 R_HMR_3129 Beta oxidation of 
even-chain fatty acids 
(mitochondrial) 
R_r0720 Fatty acid oxidation R04740 R_HMR_3083 Beta oxidation of 
even-chain fatty acids 
(peroxisomal) 
R_r0721 Fatty acid oxidation R04740 R_HMR_3129 Beta oxidation of 
even-chain fatty acids 
(mitochondrial) 
R_r0721 Fatty acid oxidation R04740 R_HMR_3083 Beta oxidation of 
even-chain fatty acids 
(peroxisomal) 
R_r0661 Fatty acid oxidation R04170 R_HMR_3136 Beta oxidation of 
even-chain fatty acids 
(mitochondrial) 
R_r0661 Fatty acid oxidation R04170 R_HMR_3087 Beta oxidation of 
even-chain fatty acids 
(peroxisomal) 
R_T2M26D
COAHLx 
Limonene and pinene 
degradation 
R06412 R_HMR_9566 Isolated 
R_T2M26D
COAHLx 
Limonene and pinene 
degradation 
R06412 R_HMR_9565 Isolated 
R_T2M26D
COAHLm 
Limonene and pinene 
degradation 
R06412 R_HMR_9566 Isolated 
R_T2M26D
COAHLm 
Limonene and pinene 
degradation 
R06412 R_HMR_9565 Isolated 
R_C2M26D
COAHLx 
Limonene and pinene 
degradation 
R06411 R_HMR_9567 Isolated 
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Recon 2 
 
HMR2.0 
Entry Subsystem KEGG Entry Subsystem 
R_C2M26D
COAHLx 
Limonene and pinene 
degradation 
R06411 R_HMR_9568 Isolated 
R_C2M26D
COAHLm 
Limonene and pinene 
degradation 
R06411 R_HMR_9567 Isolated 
R_C2M26D
COAHLm 
Limonene and pinene 
degradation 
R06411 R_HMR_9568 Isolated 
R_RE1860C Miscellaneous R03538 R_HMR_9471 Isolated 
R_RE1860E Miscellaneous R03538 R_HMR_9471 Isolated 
R_DOLPH_L
er 
N-glycan synthesis R06258 R_HMR_7274 N-glycan metabolism 
R_DOLPH_
Uer 
N-glycan synthesis R06258 R_HMR_7274 N-glycan metabolism 
R_SMS Sphingolipid 
metabolism 
R08969 R_HMR_0736 Sphingolipid 
metabolism 
R_SMS Sphingolipid 
metabolism 
R08969 R_HMR_0735 Sphingolipid 
metabolism 
R_SMPD3g Sphingolipid 
metabolism 
R02541 R_HMR_8242 Sphingolipid 
metabolism 
R_SMPD3g Sphingolipid 
metabolism 
R02541 R_HMR_0797 Glycosphingolipid 
metabolism 
R_SMPD3g Sphingolipid 
metabolism 
R02541 R_HMR_0795 Sphingolipid 
metabolism 
R_SMPD3l Sphingolipid 
metabolism 
R02541 R_HMR_8242 Sphingolipid 
metabolism 
R_SMPD3l Sphingolipid 
metabolism 
R02541 R_HMR_0797 Glycosphingolipid 
metabolism 
R_SMPD3l Sphingolipid 
metabolism 
R02541 R_HMR_0795 Sphingolipid 
metabolism 
R_CYSO Taurine and 
hypotaurine 
metabolism 
R00893 R_HMR_3908 Bile acid biosynthesis 
R_r0708 Tetrahydrobiopterin 
metabolism 
R04639 R_HMR_4817 Biopterin metabolism 
R_r0708 Tetrahydrobiopterin 
metabolism 
R04639 R_HMR_4818 Biopterin metabolism 
R_r0709 Tetrahydrobiopterin 
metabolism 
R04639 R_HMR_4817 Biopterin metabolism 
R_r0709 Tetrahydrobiopterin 
metabolism 
R04639 R_HMR_4818 Biopterin metabolism 
R_r0778 Tetrahydrobiopterin 
metabolism 
R05048 R_HMR_4836 Biopterin metabolism 
R_r0778 Tetrahydrobiopterin 
metabolism 
R05048 R_HMR_4835 Biopterin metabolism 
R_r0777 Tetrahydrobiopterin 
metabolism 
R05048 R_HMR_4836 Biopterin metabolism 
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Recon 2 
 
HMR2.0 
Entry Subsystem KEGG Entry Subsystem 
R_r0777 Tetrahydrobiopterin 
metabolism 
R05048 R_HMR_4835 Biopterin metabolism 
R_r0120 Tetrahydrobiopterin 
metabolism 
R00428 R_HMR_4170 Biopterin metabolism 
R_r0120 Tetrahydrobiopterin 
metabolism 
R00428 R_HMR_4169 Biopterin metabolism 
R_r0121 Tetrahydrobiopterin 
metabolism 
R00428 R_HMR_4170 Biopterin metabolism 
R_r0121 Tetrahydrobiopterin 
metabolism 
R00428 R_HMR_4169 Biopterin metabolism 
R_5HTRPD
OX 
Tryptophan metabolism R02702 R_HMR_6716 Phenylalanine, 
tyrosine and 
tryptophan 
biosynthesis 
R_3HAO Tryptophan metabolism R02665 R_HMR_4228 Nicotinate and 
nicotinamide 
metabolism 
R_r0716 Unassigned R04738 R_HMR_3122 Beta oxidation of 
even-chain fatty acids 
(mitochondrial) 
R_r0716 Unassigned R04738 R_HMR_3079 Beta oxidation of 
even-chain fatty acids 
(peroxisomal) 
R_r1377 Unassigned R06982 R_HMR_3935 Tyrosine metabolism 
R_MMEm Valine, leucine, and 
isoleucine metabolism 
R02765 R_HMR_3213 Valine, leucine, and 
isoleucine metabolism 
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